University of Montana

ScholarWorks at University of Montana
Graduate Student Theses, Dissertations, &
Professional Papers

Graduate School

2003

Part One. Synthesis of iso-polydiacetylenic precursor. Part Two.
The study of asymmetric addition of dimethyl thiophosphite to
imines
Troy Mason Voelker
The University of Montana

Follow this and additional works at: https://scholarworks.umt.edu/etd

Let us know how access to this document benefits you.
Recommended Citation
Voelker, Troy Mason, "Part One. Synthesis of iso-polydiacetylenic precursor. Part Two. The study of
asymmetric addition of dimethyl thiophosphite to imines" (2003). Graduate Student Theses, Dissertations,
& Professional Papers. 9469.
https://scholarworks.umt.edu/etd/9469

This Dissertation is brought to you for free and open access by the Graduate School at ScholarWorks at University of
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an
authorized administrator of ScholarWorks at University of Montana. For more information, please contact
scholarworks@mso.umt.edu.

Maureen and Mike
MANSFIELD LIBRARY

The U niversity o f

Montana
Perm ission is granted by the author to reproduce this material in its entirety,
provided that this material is used for scholarly purposes and is properly cited in
published w orks and reports.

**Please ch eck "Yes" or "No" and provide signature**

Y es, I grant perm ission

^

N o , I do not grant perm ission

Author's
Date:

j>

^

____________

__________________________

___________

A ny copying for com m ercial purposes or financial gain m ay be undertaken only with
the author's exp licit consent.

8/98

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

PART ONE
SYNTHESIS OF ZSO-POLYDIACETYLENIC PRECURSOR

PART TWO
THE STUDY OF ASYMMETRIC ADDITION OF DIMETHYL
THIOPHOSPHITE TO IMINES

by
Troy M. Voelker
B.S. Utah Sate University 1997
presented in partial fulfillment o f the requirements
for the degree Doctor o f Philosophy
The University o f Montana
Department o f Chemistry
May 2003
Approved by:

ierson

Dean, Graduate School

S '2 3

- 0 3

Date

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

UMI Number: 3093833

Copyright 2003 by
Voelker, Troy Mason

All rights reserved.

®

UMI
UMI Microform 3093833
Copyright 2003 by ProQuest Information and Learning Company.
All rights reserved. This microform edition is protected against
unauthorized copying under Title 17, United States Code.

ProQuest Information and Learning Company
300 North Zeeb Road
P.O. Box 1346
Ann Arbor, Ml 48106-1346

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Copyright b y Troy M. V oelker, 2003
All rights reserved

ii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Voelker, Troy M. Ph. D., February 2000

Chemistry

Synthesis o f Ao-Polydiacetylenic Precursor’s
and
The Study o f A sym m etric Addition o f Dimethyl Thiophosphite to Imines
Director: Charles M. Thom pson

This research has been divided into two subjects. The first w as com prised o f the study
o f vinyl triflates and term inal acetylenes used as precursors for Ao-polydiacetylenic
precursors. The second study was to assess the asymm etric addition o f dimethyl
thiophosphite to im ines with chiral auxiliaries.
In the first study, palladium catalyzed cross-coupling o f a term inal acetylene and vinyl
triflate, which produced a dim er that could be converted into either a terminal acetylene
or vinyl triflate was accomplished. The dim er was then converted into a terminal
acetylene and coupled with the vinyl triflate m onom er to produce a trim er that allowed
linear chain growth. The sequence was repeated until the tetram er was produced
establishing the possibility for Ao-polydiacetylenic precursors to be made by the
established method.
In the second study dimethyl thiophosphite was added across im ines made from chiral
amines and aldehydes. The diastereom er ratio ranged from poor (10:9) to good (11:2)
and was independent o f hydrogen bonding auxiliaries. Separation o f diastereomers was
accomplished w ith some o f the compounds using silica chrom atography. The
asymmetric dealkylation using potassium ethyl xanthate was studied and found to be
successful on the com pounds that did not possess a hydroxy functional group on the
chiral amine.
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Chapter 1

Introduction

A. M olecular m aterials

For m ore than a century, synthetic chem ists have dem onstrated their ability to
construct m olecules and materials capable o f fulfilling a huge variety o f requirem ents in
terms o f m echanical, physical, and chem ical properties. The electronic properties o f
linear n-conjugated systems (LCSs) have been the subject o f grow ing im portance in
many areas o f m odem chemistry and also in the physics o f condensed m a t t e r . A t the
molecular level, LCSs represent the simplest m odels o f molecular w ires, w hich together
with their com plem entary functions such as m olecular switches, or logical gates, have
contributed to the emergence o f the concept o f m olecular electronics.[3] LCSs constitute
the elemental bricks o f m olecular materials that have given rise to considerable research
effort in basic and applied material science w ith the view to develop new materials and
technological advancem ents.^
Until recently, conjugated polymers (C P ’s) represented the best know n prototypes
o f LCSs. The unique properties o f C P’s originate from their extended n-conjugated
system delocalized over a large number o f recurrent m onom er units. The basic model o f
this class o f m aterials consists o f alternate single and double carbon-carbon bonds. A
compound is in conjugation when two or more double bonds are separated by alternating
single bonds as in 1,3-butadiene. The n systems o f the two conjugated double bonds are
delocalized over the four carbons and electron flow m ay be possible.
1
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In plastics, such as polyacetylene, the conjugation extends along the complete
backbone o f the polym er and has been used to install electronic properties in m aterials
that w ould norm ally be considered insulators. In becom ing electrically conductive, a
polymer has to im itate a metal, that is, the electrons needs to be free to m ove and not
localized to individual atoms. The first condition for this is that the polym er consists o f
conjugated double bonds. However, it is not enough to have conjugated double bonds.
To become electrically conductive, the polym er has to be disturbed - either by removing
electrons from (oxidation), or inserting them into (reduction) the material. The process is
known as doping.
W hen describing polymer molecules, a bonds and n bonds are distinguished by
their individual properties. The %bonds are fixed, im mobile, and form the covalent bonds
between the carbon atoms. The n electrons in a conjugated double bond system are also
relatively localized, though not as strongly bound as the a electrons. Before an electrical
current can flow along the molecule, one or m ore electrons have to be rem oved or
inserted. I f an electrical field is then applied, the electrons constituting the n bonds can
move rapidly along the molecule chain. The conductivity o f the polym er chains will be
limited by the fact that the electrons have to "jump" from one m olecule to the next.
Hence, the chains have to be well-packed in ordered rows for conducting to occur.

2
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As m entioned earlier, there are two types o f doping, oxidative or reductive. In the
case o f polyacetylene, the oxidation or reduction reaction equations are written as
follows:

Oxidation w ith halogen (p-doping):

[CH]n +

I2

--------► [CH]nx+ + x I3

Reduction w ith alkali metal (^-doping): [CH]n + x N a

H

H

► [CH]nx~ + x N a+

H

w h e re [ C H J
H

H

H

The doped polym er is a salt. However, it is not the iodide or sodium ions that
move to create the current, but the electrons from the conjugated double bonds.
Furthermore, if a strong enough electrical field is applied, the iodide and sodium ions can
move either tow ards or away from the polymer. This m eans that the direction o f the
doping reaction can be controlled and the conductive polym er can easily be switched on
or off. A pplications o f such materials have been used in the production o f photodiodes,
flat television screens based on light-emitting diodes (LED), and luminous traffic signs.
The game illustrated in Fig. 1.1 offers a simple model o f a doped polymer. The
pieces cannot m ove unless there is at least one em pty "hole". In the polym er each piece
is an electron that jum ps to a hole vacated by another one. This creates a movem ent along
the molecule or an electric current.

3
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Figure 1.1. A game that illustrates polym er doping. In order to align
the num bers o f the puzzle a piece must be m oved into the hole
creating a new hole w hich then allows another piece to be moved.

B. Arom aticity

A nother principle in chem istry that is a direct result o f a conjugated bond system
is aromaticity. The m ost com m on aromatic com pound is benzene. Benzene has the
molecular form ula CefU and is cyclic compound w ith three double bonds that are in
conjugation, and therefore, the tc electrons are delocalized around the entire ring. Unlike
other alkenes, w hen benzene undergoes electrophilic addition it is quickly followed by
elimination to restore the stable aromaticity, suggesting that this class o f compounds
should be treated different then other alkenes. In 1926, a British chem ist nam ed Sir
Robert Robinson, recognized that the compounds that had been classified as aromatic
always had six electrons, in either n or nonbonding orbitals, in a planar ring. Robinson
suggested that there was a special stability associated w ith what he called an aromatic

4
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delocalized n orbitals
i

r

overlap

Energy
4—

f— 4 —

f f —

f—

6 degenerate p orbitals
7C

Figure 1.2. M olecular orbital diagram o f benzene.

sextet. As the theory o f m olecular bonding developed, it becam e clear that a sextet was
indeed a significant number, corresponding to the num ber o f electrons that fill the three
bonding m olecular orbitals o f benzene (Fig. 1.2). Few er electrons would leave unpaired
electrons in the bonding orbitals and create a species with radical characteristics.
Additional electrons would have to go in antibonding m olecular orbitals and would create
an unstable, high-energy species. Benzene has a filled shell o f m olecular orbitals, ju st as
an element such as argon has a filled shell o f atomic orbitals.
In 1931, a German chem ist named Erich Hiickel dem onstrated that there were
other numbers o f electrons that corresponded to filled shells for sm aller or larger rings.
He proposed w hat is now known as Hiickel’s rule: “any conjugated m onocyclic polyene
that is planar and has 4n + 2 pi electrons (n = 0, 1, 2, etc.) will exhibit the same stability
that is associated with benzene.”
Benzene is the ideal aromatic compound. The six carbon atoms in the ring are
sp2- hybridized, so their regular bond angles o f 120E create a perfect hexagon. The

5
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molecule is planar and totally symmetrical. Because all the ring atoms are carbon, no
differences in polarity are introduced by the presence o f other elements in the ring. The
electrons are delocalized evenly over the entire ring. Larger rings w ith conjugated cis
double bonds cannot be planar because the bond angles required for such geometrical
figures cannot be achieved. However, trans double bonds are possible for large carbon
rings. Such a configuration puts hydrogen atoms on the inside o f the ring where they
occlude each other and prevent the molecule from being planar. O nly in rings consisting
o f 18 or m ore carbon atoms is this steric hindrance rem oved from the m olecule (Fig. 1.3).
Although these larger rings, called annulenes, do not have the stability associated with
benzene they do have some o f the properties associated w ith aromaticity. Annulenes
share properties with aromatic compounds and LCSs. These carbon allotropes possess
complete Tr-conjugated systems that have a limitless boundary o f carbon sk eleto n s.^

Figure 1.3. [18]Annulene

6
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C. Annulenes

A continuing question in the concept o f arom aticity is the effect o f ring size.
Various theoretical predictions have suggested that in the upper range o f ring size,
roughly estim ated to be anywhere from 18-30 carbons, the special properties associated
with aromatic rings will disappear and these allotropes will begin to behave like simple
p o ly e n e s .A lth o u g h past synthetic work has provided rings o f this size,[8] the
conformational m obility o f these simple annulenes m ade it difficult to evaluate their
properties in terms o f polyene vs. aromatic character.1^ The dehydroannulenes,
containing acetylene-cum ulene bonds, are much m ore structurally rigid and provide a
more ideal platform for the study o f aromatic properties in large rings. However,
assessing the question o f polyyne vs. aromatic character in this series is again difficult
because o f the unknown alkyne-cumulene anisotropy effects along w ith the unknown
effect o f having short fixed bonds in the annulene perim eter.'10^
The ideal molecules for studying the aromatic conjugation are those that possess
rigid, planar annulene perim eters in which all o f the annulene bonds are equivalent.
Sondheim er and coworkers accomplished the first synthesis
o f [iI]annulene 1, which contains a continuous m olecular

H

H

orbital around the ring. Cyclic com pound 1 possesses 18
^-electrons in conjugation and was the first fully
H
conjugated m onocyclic system known with more than the
classical sextet.[12] This m ilestone in both synthetic and
H

H

physical organic chem istry provided experimental support

7
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j

for the Hiickel rule defining aromaticity and provided a spark for the synthesis o f a
diverse array o f m acrocylic

71-electron

perimeters.

D. O xidative Acetylene Coupling

The synthesis o f fully conjugated m acrocyclic systems is prim arily based on
acetylenic coupling (Fig. 1.4). First discovered by G laser[l3] in 1869 and later applied by
Baeyer| l4] to the form ation o f near infinite, all carbon chains know n as carbyne, the
reaction never achieved broad application because the isolation o f explosive copper
acetylide was required for the coupling reaction. It was not until m odifications to the
Glaser coupling by Englinton and G albraith115] whom m ade use o f cupric salts and donor
solvents such as pyridine, or Flay116J whom discovered the conditions for homocoupling,
and Cadiot-Chodkiew icz[171 that developed the heterocoupling reaction that acetylenebased m olecular architecture took hold in synthetic organic chem istry.[I8] Considerable
synthetic efforts are currently targeting uncom m on m olecular architectures and
functionally advanced m aterials using acetylene coupling m ethodologies.

8
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H
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Figure 1.4. Acetylenic coupling reaction conditions.

E. Radialene

W ithin the fam ily o f annulene chem istry is a subset called radialenes. Radialenes
are a series o f all-m ethylidene-substituted cyloalkanes o f m olecular form ula CnH n
(Fig. 1.5) and has been an active field o f chem istry for the past tw enty years.'[19J By
inserting ethynediyl or buta-l,3-diynediyl moieties into the cyclic radialene framework, a
carbon rich hom ologous series o f expanded radialenes is obtained w ith the molecular

9
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C„Hn
R adialene

C3„Hn
E xpanded R adialanes
x = 0, 1 ,2 , ...etc.

Figure 1.5. Radialene and expanded radialenes’s defined by the
form ula CxnH n (x = 1,2, 3).

formula CnH 2 n and CnH 3 n.[201 In contrast to their constitutional isom ers w ith endocyclic,
linearly conjugated double bonds such as benzene and cyclooctatetraene, radialenes
possess an uninterrupted cyclic arrangem ent o f cross-conjugated n systems. The first
radialene synthesis reported was hexaethylidenecyclohexane 2 (Fig 1.6) in 1961.[211
Radialenes have always been overshadowed by the linearly conjugated polyenes and the
arenes in preparative and industrial organic chem istry. Yet recent interest in this
radialenes has increased significantly because new methods o f synthesis m ake them more
accessible, and they are potential candidates for the construction o f organic conductors
and ferrom agnets.[22]
The highly symmetrical structure o f radialenes, suggested by their constitutional
formulas is not only aesthetically appealing but also stimulates the fantasy o f the chemist.

10
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It is thus not surprising that the search for a fitting trivial name for these regular
structures with the double bonds “radiating” from the central ring led to the name
“radialene” .1221 Although this term was coined originally for the
hexam ethylenecyclohexane 2, it was quickly adopted for the w hole series. To
differentiate betw een its various members, a nom enclature was adopted in which the
number o f the exocyclic double bonds was put in parentheses in front o f the word
radialene, e.g., [231radialene (n = 3, 4 ,..).

650° C
10'1Torr

10"3 Ton-

,CI

Figure 1.6. Two thermalytic routes to radialene (2).

M ethods o f preparing radialenes fall into two general synthetic strategies: (1)
olefm -forming reactions at an already existing cycloalkane skeleton, and (2) thermal,
photolytic, or m etal-induced cylooligom erization reactions o f suitable1231 cumulenes (Fig.
1.6). The latter m ethod has turned out to be the more versatile and successful one so far,
although it still cannot compete in product selectivity w ith the former.
Diederich and B oldi[24] were the first to synthesize a series o f expanded radialenes 3-5
(Fig. 1.7). The m ost direct synthetic route to these compounds w ould be by means o f an
Eglinton-G laser cyclization o f tetraethynylethene 6. Unfortunately, this m ethod did
not afford any isolable quantities o f the macrocyles but instead led to oligomeric
m aterial.[24] To favour cyclization and provide 3-5 over com peting polym erization

11
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R

R
R

R

R

R

5
R = TIPS (triisopropylsilyl; iPr3Si-)

Figure 1.7. Perethynylated expanded radialenes synthesized by
Diederich and B oldi.19

reactions, the authors had to access the radialenes by first m aking the dimeric compound
9 (Scheme. 1.1). The dim er was prepared by sequential, kinetically controlled
deprotection o f trim ethylsilyl (TMS) and triethylsilyl (TES) in the presence o f the
analogous triisopropylsilyl (TIPS) protected groups o f com pound 7. After removal o f the
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R1
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R3
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+
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(15%) (20%)
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10: R = H

•TIPS
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•TIPSTIPS.

CuOAc
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11: R = TES
12: R = H
10

+ 12

CuOAc

4
(15%)

N

Schem e 1.1. Synthesis o f perenthynylated radialenes.
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•TIPS

TMS group, 8 was homocoupled under Eglinton-G albraith conditions to afford dim er 9.
Rem oval o f the TES protecting group to afford 10 and a second hom ocoupling, produced
3 and 5 in 15% and 20% yield.
In order to prepare the pentagon radialene 4, the trim er 11 had to first be produced
via a heterocoupling betw een 6 and 8. After removal o f the TES protecting group an
oxidative cyclization between 12 and 10 produced 4 (15%) as the m ajor product with a
small am ount o f 3 and 5 from the respective hom ocoupling reaction. All three radialenes
are readily soluble, highly stable compounds with m elting points above 260EC. The
stability o f the radialenes indicates the absence o f free term inal alkyne groups which
generally destabilize polyacetylenic n systems.
The particularly high stability o f 3-5 may w ell be due to inefficient cross
conjugation, w hich cannot compete w ith linear 7i-electron conjugation in these
system s.[25] Inefficient cross-conjugation could be a general stabilizing principle o f
unsaturated carbon-based matter: fullerene C6o is best described as a cross-conjugated
molecule with radialene[23J substructures and graphite m ay also be viewed as cross
conjugated. The high solubility o f 3-5 probably is m ore due to the presence o f the TIPS
groups rather than cross conjugation but this phenom enon still leaves hope for the
construction o f larger m olecules with similar properties.
Although the production o f expanded radialenes is rem arkable in itself there are
some drawbacks to the syntheses. It is four steps to prepare the tetraethynylethene 6 and
although the protecting groups are a product o f the coupling reaction to make 6 the
subsequent selective, kinetically controlled deprotection to afford the dim er 9 and trimer
10 resulted in overall low yields and significant losses o f material from over deprotection.
An important facet to radialene synthesis that arose from these experim ents is the
14
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m ethodology o f a stepwise synthesis o f polymeric m olecular rods. Although the direct
synthesis from a single m onom er unit is possible the by-products from such a reaction
obviates any type o f purification.

F. Iterative R adialene Synthesis

The challenge exists to develop supramolecular chem istry into a more systematic
science, and therefore, methods need to be available for encoding m olecular building
blocks in a way that is simple, yet offers total specifity.[26] In order to mimic the bestknown natural supram olecular systems such as the nucleic acids and proteins, synthetic
methods that allow efficient, but versatile construction o f com plex m olecular objects
from simple building blocks are desirable. Dissections o f structures 3-5 indicate that the
m ajor drawback to the syntheses is not the low yielding oxidative coupling but rather the
inefficient choice o f tetraethynylethene as the m onom er unit. The num erous steps to
produce tetraethynylethene is sim ply too extensive to m ake production o f the
macrocycles on a large scale impossible. So there is an obvious need for further
developm ent o f acetylenic building blocks that are easy to prepare and functionalize.
The stepwise construction o f networks, in other words the transform ation o f
appropriate m onom ers into successively larger oligomers, is the m ost prom ising
approach. In this approach the solubility o f the larger system can be estimated from the
properties o f the sm aller molecules. If necessary the m onom ers can be m odified to
improve the desired properties o f the anticipated network. Any repetitive m ethodology
for assem bling covalently linked sequences o f monom eric units m ust be able to control
chain length, sequence order o f monomers, and end-group functionality. In addition, the
15
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method m ust be efficient and versatile. The solid-phase m ethods pioneered by
M e rrifie ld ^ rem ain the m ethods o f choice o f complex polypeptides, especially when
each successive unit is different from the previous. However, it is clear that this
approach is not easily adapted to other complex m olecular systems.

A pB j

d ep ro tectio n

Coupling
Ap-{BA)-B___
/

V - B
J—

i

-A-(BA)-B-

Figure 1.8. Iterative cycle to synthesis o f radialene precursors.

22

For sequences that are periodic or sequences that have extensive periodic
segments, the repetitive method established by M o o r e ^ (Fig 1.8) is considerably more
efficient as long as you can avoid solubility and purification problem s. The cycle begins
by selective deprotection at each o f the two ends o f the diprotected m onom er APBP,
yielding the m onoprotected intermediates APB and ABP. These are often coupled to give
the dimer A pB A Bp protected in the same m anner as the m onom er unit. The process can
be repeated n times to give a sequence o f length 2". Sequences o f length other than 2", as
well as sequences having particular arrangement o f co-m onom er units, can be realized by
merging parallel repetitive cycles. For example, a hexam er sequence is achieved by
com bining tetram er and dim er sequences.

16
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A com m on feature in the preparation o f carbon-rich systems is the use o f the C-C
triple bond as a functional group and linking unit. The alkyne group is the only easily
preparable all-carbon building block; terminal alkyne functions can be linked to sp2-C-X
( X = halogen) m olecules readily and in high yields with certain oxidative coupling
procedures. Thus, the acetylene function is indispensable not only in the construction o f
carbon-rich structures but also in the synthesis o f larger rings. The relative rigidity and
linearity o f the acetylene fragment is a further advantage in the synthesis o f rigid and
uniform ly shaped structures. So if the acetylene functional group can not be removed
from the m ethodology o f the synthesis then the vinyl coupling unit is the only functional
group left to be explored.
A typical synthesis is illustrated by the palladium -catalyzed cross coupling1291 o f
monom ers TM S!A !B r and H!B!N=N!N Et2 which has trim ethylsilyacetylene and 1-aryl3,3-diethyltriazene end group functionalities (Scheme. 1.2).[261 R eaction o f TMS1AB!
N =N!NEt2 w ith m ethanol in the presence o f a catalytic amount o f potassium carbonate
gives term inal acetylene H !AB!N =N !N Et 2 . In contrast, reaction o f TMS! AB!N=N!N Et2
with methyl iodide gives aryl iodide TMS!AB!I. Interm ediates H !A B !N =N !N Et2 and
TMS1AB1I are then cross-coupled to give tetram er H! (AB)2N =N !N Et2 w hich has the
exact same end group functionalities as dimer

17
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C H ,I
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Pd'
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Schem e 1.2. Controlled synthesis o f phenylacetylene sequences.
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H !AB!N =N !N Et 2 . This process can be repeated n times to give a sequence o f length 2".
A key to the success o f this approach is that trim ethylsilylacetylene and
1-aryl-3,3-diethyltriazene function very effectively as com plem entary protecting groups
for terminal acetylene and aryl iodide. Each o f the two protecting groups can be
selectively rem oved in the presence o f the other, and both protecting groups are stable to
the cross-coupling reaction conditions. After a few iterations o f the sequence welldefined phenylacetylene sequences (PAS) can be used to prepare phenylacetylene
macrocyles (PAM). Deprotection o f both m asking groups from the sequence’s termini
give difunctional interm ediates such as H-(AB)6-I. Upon intram olecular cyclization o f
PA S’s rigid m acrocycles are obtained with larger internal diameters in high yield under
optimized cyclization conditions. Although the synthesis does not provide a route to
radialene compounds it does define the m ethodology em ployed by m ost in the radialene
research community.
W hile studying triflate derivatives, Stang^30^ prepared com pound 13, w hich was
singled out as a class o f m olecules ideally suited to probe the electronic characteristics o f
cross-conjugation in organic molecules and provide a m onom er unit suitable for radialene
synthesis. Tykw inski[311reported the iterative synthesis and characterization o f this class
o f oligomers. Palladium -catalyzed coupling o f term inal alkynes w ith vinyl triflates[32]
provided an alternative to coupling terminal alkynes to vinyl halides and an efficient
route to the desired oligomers. Tykwinkski assem bled the A o-polydiacetylene (PDA)
beginning w ith a palladium catalyzed cross-coupling o f trim ethylsilylacetylene and vinyl
triflate m onom er 13 to afford 14 (Scheme. 1.3). Protodesilylation o f 14 gave the
deprotected diyne that could then be coupled with 13 to afford trim er 16. U sing 16,
iteration o f the protodesilylation and coupling sequence gave pentam er 18. The assembly
19
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o f radialene 21 required protodesilylation o f 18 followed by cross coupling with
dibrom oolefm 20. A lthough dilute reaction conditions was necessary to delineate the
formation o f linear oligom ers the cyclization reaction did require seven days for
completion. W ork up and column chrom atography gave the pure m acrocycle in modest
yields due to decom position during purification.

TMS

13

14: R = TMS
15: R = H

k 2c o 3

+

X

Br

3
K2C 0 3

16: R = TM S
17: R = H

K2C 0 3 C X

R

19: R = TMS
20: R = H

Br

20

21

S chem e 1.3. Iterative synthesis o f A o-PD A ’s.
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The w ork done by Tykwinski proved that 13 is an effective and efficient building
block for the production o f iso-PDA ’s and radialenes. The synthesis does have a limit in
terms o f radialene synthesis due to the fact that chain elongation takes place on both ends
o f the Ao-PDA. Plus, this type o f approach does not allow for chain growth to proceed in
a geometric fashion due to only the m onom er unit being used for chain elongation rather
then being able to couple a dim er to a dimer, or a trim er to a dimer, etc.

G. Statem ent of the Problem

Expanded radialenes, molecular wires, and polym ers with polyacetylenic,
conjugated backbones are compounds o f extended C-cores and are m aterials with unusual
structural and electronic properties. M acrocylic ring systems containing multiple
acetylenic units m ay have possible ligand binding properties or provide a core for the
construction o f expanded dendrimers. Rigid acetylenic m olecular rods o f defined length
can serve as precursors to molecular wires for potential electronic devices. The
preparation o f acetylenic precursors for the construction o f such m olecules has been an
interest in synthetic chem istry in the past decade. The goal o f this project is to develop a
novel synthetic route to the construction o f polyacetylenic backbone precursors based on
palladium cross-coupling reactions between vinyl triflates and term inal acetylenes.
It was in the interest o f this investigator to study the possibility o f using 13 in an
iterative synthesis that would adapt to M oore’s m ethodology. By using 22, the precursor
to 13 and readily accessed from bzs-trimethylsilyl acetylene and the acid chloride, an isoPD A with geom etric growth m ay be realized (Scheme 1.4). By using the ketone and the
trimethylsilyl group o f 22, a set o f com plim entary protecting groups for the coupling
21
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reaction is realized. Specifically, if 22 were converted to triflate from the ketone, and
then cross-couple the triflate with the terminal acetylene acquired from desilylation o f 22,
a dimer would be produced that has the same protection scheme as the monomer.
Through the iterative process established by M oore, an iso-PDA could be produced with
the same 2" chain growth. Once the iso-PDA has reached the length desired for the
macrocycle both ends o f the chain are then deprotected and fused to make the radialene.

22
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Schem e 1.4. Proposed synthetic design for A o-PD A ’s.
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Chapter 2

Synthesis
A. Iso-PDA fram ework

An iterative method o f chain elongation was used to assem ble the cross
conjugated precursors to the radialenes by utilizing palladium -catalyzed cross-coupling
o f term inal acetylenes and vinyl triflates. The coupling sequence is sufficiently mild
enough to tolerate the unsaturated iso-PDA framework o f the precursors, including the
protecting groups masking the active coupling units, and allows m odular incorporation o f
the different substituents required to m aintain solubility or vary electronic effects.
The m onom er unit 22 is made from the reaction o f 6A-(trim ethylsilyl)acetylene
with isopropyl acyl halide under Friedel-Crafts conditions (Schem e 2.1). Isopropyl acyl
chloride was chosen as the acid chloride because once it is converted to the
isopropylidene it could be distinguished by its singlet in the ^

N M R , m aking spectral

analysis less com plex on the radialene product. The reaction is conceived as an
electrophilic displacem ent o f one trimethylsilyl m oiety by an acyl group which proceeds
cleanly because o f the electron-withdrawing power o f the acyl substituent deactivates the
ethynyl-silicon bond o f the product toward further attack.[33J

The acyl group which

inhibits the breaking o f the ethynyl-silicon bond under Friedel-C rafts conditions enhances
the reactivity o f the trim ethylsily group toward nucleophilic displacem ent and can be
cleaved by weak base. The TM S group o f 22 was selectively cleaved with a 1:8 solution
o f 0.01M borax(aq) in methanol in 36 h at rt but was found to be too volatile for the
synthetic scheme. So to add some bulk to the m onom er unit and som e diversity to the
24
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Schem e 2.1. Synthesis o f m onom er coupling com pounds (vinyl
triflate and term inal acetylene).
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'H NM R spectrum , cyclohexyl acid chloride was used as a co-m onom er in the production
o f the radialene precursors. Gas chrom atography (GC) was used to track the progress o f
the desilation reaction by monitoring the decrease in area o f the l-cyclohexyl-3trim ethylsilanyl-propynone peak (Rt = 8.40 min) and the rise o f the 1-cyclohexyl
propynone, 31, peak (Rt = 6.44 min).
Standard conditions for making the triflate[34] were attempted, but all afforded,
along w ith left over starting material, tarring and very low yields, or no desired product.
The triflates 32 and 33 were eventually prepared by the reaction o f the corresponding
ketone with the bulky base 2,6-di-t-butyl-4-m ethylpyridine and triflic anhydride in
CH 2CI2 in 78% and 74% yield.1^

Use o f the non-nucleophilic, sterically hindered 2,6-di-

t-butyl-4-m ethylpyridine rather then standard bases was essential in this step.
Triethyl am ine, pyridine, and collidine result in heterogenous reaction conditions as the
anhydride reacts with these nucleophiles affording amine salts that precipitate out o f
solution. The sterically hindered base 2,6-di-i-butyl-4-m ethylpyridine acts as a true
Lewis base and is incapable o f reacting with the anhydride which allows the carbonyl
oxygen to attack the anhydride and increases the rate o f the reaction.[30] After
nucleophilic attack by the carbonyl oxygen 2,6-di-t-butyl-4-m ethylpyridine scavenges the
proton form the a carbon and forms a salt. The amine salt form ed in the triflate reaction
can be collected and the 2,6-di-t-butyl-4-methylpyridine base can be recycled if desired
for future reactions. A GC was used to m onitor both o f the triflate reactions and the
structures o f 32 and 33 w ere confirmed by the triflouromethyl quartet in the l3C spectrum
(Fig. 2.1).

26
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J=

320,4 Hz
CF

TMS

13
Figure 2.1. C N M R spectrum o f the isopropyl vinyl triflate
showing the quartet o f-C F j

C. H eck Coupling

Cross-coupling o f 32 and 34 under standard H eck conditions did not afford the
desired product 35 (Scheme 2.1), but rather an insoluble thick black tar and recovered
vinyl triflate. The initial thought was that the enol tautom er o f the ketone was forming
under the basic conditions o f the cross-coupling reaction and thus consum ing the terminal
acetylene starting material. Since the carbonyl group is essential to m ake the vinyl
triflate a protection scheme was devised in order to stop the enol form ation (Scheme 2.2).
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Schem e 2.2. Protection o f the a,p-unsaturated ketone and
palladium cross-coupling.

Since the protecting group would have to be stable to the basic reaction conditions
used in the desilation and cross-coupling reactions the 1,3-dioxolane m oiety was the most
attractive choice. Several attempts at ketalization o f 22 w ith typical m ethods[35] using
ethylene glycol in the presence o f various catalysts, such as pyridinium p toluenesulfonate, p-toluenesulfonic acid, or Am berlyst 15 ion exchange resin, resulted in

28

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

either no product or a complex mixture o f products as indicated by N M R, GC, and TLC
analysis. The m ost successful standard procedure was the use o f
2,2-dim ethylpropanediol andp-T sO H refluxed in benzene for 48 hrs w hich still only
produced a 45% yield o f the ketal.
To avoid such forcing conditions, a m ore facile approach was needed. Noyori
reported an efficient ketalization procedure involving bN -trim ethylsilylethylene glycol
(BTSE) and M e3S iO T f as reagents on a,P-unsaturated ketals.[36] The idea is to shift the
equilibrium o f the reaction toward the products by forming the very stable
hexam ethyldisiloxane. The isopropyl m onom er 22 was chosen to m ake the ketal because
the 'id peaks o f the m ethyl groups could be easily distinguished from the ketal protons.
The Noyori reaction conditions were conducted on 22, the progress m onitored by GC,
and the isolated product had the expected 'H spectrum for the ketal group (Fig. 2.2). The
yield was vastly im proved (87%) and 36 became available for further study
Once the ketal was installed desilation could be done under m ore basic conditions
without the loss o f starting material or possible M ichael additions. The use o f K 2 CO 3
decreased the time o f this step from 36 to 3 h. Palladium catalyzed cross-coupling o f

33 and 38 under standard Heck conditions led to the formation o f 39 (Schem e 2.2). But
all attempts to rem ove the ketal protecting group from 39 led to little or no product 40. It
became obvious that the direct coupling o f 32 and 34 should be explored under a variety
o f conditions in order to avoid a large loss o f m aterial to protection and deprotection.
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TMS

Figure 2.2. 'H N M R o f 2-m ethyl-3-[l,3]dixolane-l-trim ethylsilyl-lpentyne showing the ketal protons.

In order to explore different conditions for the Heck reaction it was prudent to
examine the m echanism o f the cross-coupling reaction (Fig. 2.3). The first step o f the
catalytic cycle is the oxidative addition aryl halide to the putative 14-electron complex
Pd0(PPh 3)2 to afford a cj-arylpalladium (II) complex. The second step is a nucleophilic
attack on tra«5-ArPdX(PPh3)2 with a sy«-addition o f the olefm. The final product is
generated by a p-hydride elimination via a base. Cross-coupling reactions are catalyzed
by Pd°(PPh 3 )4 , but it has been established that Pd0(PPh 3)2 , w hich forms after two
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Figure 2.3. Pd° catalyzed cross-coupling reaction m echanism.

decom plexations o f PPI13 is the transient reactive species in the oxidative addition o f
ArX. However, its concentration is extremely low because it is involved in an
endergonic reaction w ith the m ajor but unreactive species Pd0(PPh 3 )3 . The result o f the
equilibrium is a low turnover rate in the cross-coupling cycle w hich in turn means longer
reactions times and loss o f the terminal acetylene due to base instability. Reducible
palladium (II) com plexes such as P duCl2 (PPh 3)2 was considered a possible better
precursor since their reduction in situ was expected to yield quantitatively the reactive
Pd0(PPh 3)2 complex, but the need for a strong base again negated this route. Since the
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problem o f the reaction seemed to be with the base, a study was done testing the stability
o f 34 w ith a variety o f bases.
B y sim ply placing a small aliquot o f 34 in some test tubes w ith benzene followed
by the addition o f an amine base and monitoring by GC and color the decom position of
34 could be followed by the reduction in peak 6.44 min and the rise o f several peaks that
were never analyzed. The three bases that had little or no reaction w ith 34 were the bulky
base 2,6-di-f-butyl-4-methylpyridine, 2,6-di-f-butylpiperidine, and H unig’s base.
Although all three bases still resulted in decom position o f 34 it was a slow degradation.
All the bases were tried in the cross-coupling reaction and only H unig’s base gave
satisfactory results. 2,6-Di-f-butyl-4-methylpyridine and 2,6-di-f-butylpiperidine reaction
times were long requiring several days and up to 10 eq. o f 34 in order for full
consum ption o f vinyl triflate 32. The reaction with H unig’s base was complete in 48 h
and only used 5 eq. o f 34 to complete the reaction. W ith the cross-coupling reaction
conditions established, 35 was made successfully via coupling o f 32 to 34 (Scheme 2.3).
The reaction was m onitored by GC with the decrease o f the starting m aterial peaks (32,
R t = 7.1 min; 32, Rt = 6.4 min) and the growth o f a new peak (R t = 11.2 min). 'H NMR
analysis confirm ed product 35 with the ]H N M R spectra showing both the methyl
singlets from 32 and the TM S singlet from 34 (Fig. 2.4, 2.5).
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Figure 2.4. ]H NM R spectra o f l-Cyclohexyl-4-isopropylidene-6-trim ethylsilyl2,5-hexyne-l-one 35.
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Figure 2.5. A; ,3C NM R full spectra o f l-C yclohexyl-4-isopropylidene-6trim ethylsilyl-2,5-hexyne-l-one 35. B; 220-90 ppm. C; 60 - (-)10 ppm.
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Schem e 2.3. H eck coupling with H unig’s base, attem pt at the production o f
the dim er vinyl triflate, and route to the dim er term inal acetylene.

W ith dim er 35 m ade successfully, the next iteration step required the preparation vinyl
triflate 41 and term inal acetylene 42 (Fig. 2.6). The terminal acetylene was prepared
successfully using the same conditions (0.1 M borax(aq)) used to m ake the m onom er unit.
The vinyl triflate dim er 36 was detected by 13C N M R but was unstable to silica gel and
proved to be difficult to purify. Other methods o f purification were tried; alumina gel led
to the same decom position as silica, vacuum distillation never resulted in any product, the
oil was sim ply to unsuitable for recrystallization, and even freezing the product in a
benzene matrix still resulted in a black tar. Using crude 35 in the H eck coupling reaction
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Figure 2.6. A; *H N M R and B ;UC N M R o f the dimer term inal acetylene.
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was tried but either the vinyl triflate decomposed during the reaction or byproducts
poisoned the palladium catalyst. In an effort to save product and time a new scheme was
put in place that w ould make the z'so-PDA radialene precursor via coupling a monomer
unit to the chain at each step (Scheme 2.4). The new approach w ould still allow many
different m onom er units to be incorporated into the Ao-PDA but would require extra
steps to achieve the desired chain length.

Pd(PPh3)4
Cul

TMS

OTf
TMS

43

43; 59%

33

42

0.01 M B o rax ;
M eOH

44; 84%
TMS

Pd(PPh3)4
I Cul

OTf

44

+
TMS

32

45; 36%

Schem e 2.4. Chain elongation via m onom er coupling.
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The heterocoupling o f 42 and 33 led to the successful production o f the triraer 43.
The compounds had too high o f a boiling point to be m onitored by GC so all o f the
remaining reactions were analyzed by TLC. A silica colum n w ith EtOAc/hex (1 :99)
eluted pure 43 as light yellow oil and was verified by ‘H and l3C N M R (Fig. 2.7, 2.8).
Desilation o f 43 was accom plished with 0.1 M borax to afford 44, but its purification was
never fully elucidated due to the similar Rf values o f both 43 and 44 creating an overlap
with the two compounds in the NM R spectra. Since, 43 would be fairly inert to the
conditions o f coupling 44 w ith 32, it was used impure and did successfully produce 40,
although in m odest yield. A silica column w ith EtOAc/hex (0.5:99.5) eluted pure 45 as
dark yellow oil, that quickly turned dark red if left at rt and was verified by 'H and ,3C
N M R (Fig. 2.9,2.10).
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Figure 2.7. ]H spectra o f l-Cyclohexyl-7-cyclohexylidene-4-isopropylidene-9trim ethylsilanyl-nona-2,5,8-triyn-l-one (43).
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Figure 2.8. I3C spectra o f l-C yclohexyl-7-cyclohexylidene-4isopropylidene-9-trim ethylsilanyl-nona-2,5,8-triyn-l-one (43).
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Figure 2.9. H spectra o f 1-cyclohexyl-7-cyclohexylidene-4,10-isopropylidene12-trim ethylsilanyl-2,5,8,l 1-dodecyn-l-one (45).
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Figure 2.10. I3C spectra o f l-Cyclohexyl-7-cyclohexylidene-4,10isopropylidene-12-trim ethylsilanyl-2,5,8,ll-dodecyn-l-one (45).
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Chapter 3

Conclusions and Future W ork

A. New R adialene Scheme

The use o f acyl chlorides and bis-(trim ethylsilyl)acetylene as precursors for isoPDA framework has been a success. U nfortunately, making the vinyl triflate with the
dim er was unsuccessful and thus chain elongation could only be achieved w ith the
monomer units. In order to realize the radialenes from the iso-PDA precursors, a new
scheme for the production o f a vinyl halide will have to be im plem ented (Schem e 3.1).
Pross and Sternhell^7' established a route to vinyl iodides via a hydrazone intermediate.
The hydrazone is prepared by condensing hydrazine hydrate and the ketone in EtOH.
Then a solution o f the hydrazone and TEA is cooled to 0 EC and a saturated solution o f
iodine and THF is added to yield the vinyl iodide. An intram olecular cross-coupling
reaction with the term inal acetylene and vinyl iodide would then yield the expanded
radialene. Once the radialene has been made, a UV-vis spectroscopic analysis will be
conducted to establish the contribution o f the cross-conjugation to the overall 7t-electron
delocalization in the ring.
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Scheme 3.1. Future radialene scheme.
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Chapter 4

Introduction

A. Endogenous V asoactive Peptides

Since their discovery, endogenous vasoactive peptides have attracted considerable
interest because o f their concerted actions on the heart, vascular smooth muscle and
kidney, as well as their ability to alter the release o f horm ones and neurotransm itters.
Although m uch inform ation has been obtained regarding their vasoconstrictor and
mitogenic actions, their involvement in m odulating the activity o f the cardiovascular
system under normal conditions has not been fully elucidated. A better understanding o f
their role in pathogenesis o f a variety o f diseases such as hypertension, artherosclerosis or
active renal failure is required.[38J The endogenous vasoactive peptides presum ably act
through a variety o f m echanism s to control vascular tone and peripheral blood flow J3^
Some o f these peptides (angiotensin II, vasopressin, and neuropeptide Y) are potent
vasoconstrictors while others (atrial natriutetic peptide and bradykinin) are vasodilators
acting in parallel to maintain homeostasis.f40J These peptides are known to be released
mostly by endothelial cells to mediate vasoconstriction in response to various chemical
and physical s tim u li.^ Since the initial description o f angiotensin II-mediated
hypertension some 40 years ago, basic and clinical investigations o f the renin-angiotensin
system (RAS) have resulted in broader understanding o f cardiovascular pathophysiology
and significant advances in therapy. A ngiotensin-converting enzyme [42] inhibitors
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Figure 4.1. Pathophysiology o f the RAS. SMC indicates smooth m uscle cell
(scheme from Givertz et al. 2000).

and angiotensin receptor antagonists are now w idely prescribed for the treatm ent o f
hypertension and left ventricular dysfunction^431
Renin is released by juxluloglom erular cells in the kidney in response to renal
hypoperfusion, decreased sodium delivery, and sympathetic activation (Fig. 4.1).
Angiotensinogen produced by the liver is cleaved by renin, through the hydrolysis o f a
Leu-Val bond, to yield the inactive N-terminal decapeptide angiotensin I. Circulating
angiotensin I is in turn, converted to angiotensin II in the lungs by the action o f ACE,
which cleaves a two am ino acid fragment from the C-term inus end o f angiotensin I.|44)
ACE, or kininase II, also plays a key role in the kallikrein-kinin system by cleaving
bradykinin to inactive peptides. In addition to the horm onal effects o f circulating
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angiotensin II, all o f the necessary components o f the RAS exist in several organs and
tissues, including the heart, kidneys, and vasculature.1451
Angiotensin II exerts its actions in target organs and tissues by binding to both
angiotensin II type 1 and 2 (ATi and A T 2 ) receptors, although adverse effects in humans
seem to be m ediated prim arily by the ATi receptor (Fig. 4.2).[46] In the kidney,
angiotensin II causes sodium and w ater retention and efferent arteriolar vasoconstriction.
Constriction o f the systemic vasculature by angiotensin II causes hypertension, whereas

A TI
Platelets

A C E -ln hibito rs

NEP-lnhibitors

ACE-lnhibitors

Inactive
Products

Inactive
Products

eNOS
EDHF

Inactive
Products

Vascular
Endothelium

Vascular
Smooth
Muscle Cells

Contraction
Proliferation

Relaxation
Antiproliferation

Figure 4.2. Synergistic effects resulting from com bined ACE and NEP inhibition
are due to sim ilar m echanism s, leading to blockade o f angiotensin (AT) synthesis
and concom itant potentiation o f effects o f natriuretic peptides and bradykinin,
leading to vasodilatation, natriuresis, and im provem ent in m yocardial function. ET-1
indicates endothelin; ECE, endothelin-converting enzyme; A T, angiotensin; Thr,
throm bin; Bk, bradykinin; pGC, particulate guanylate cyclase; and sGC, soluble
guanylate cyclase (Scheme from Zhang et al. 1998).
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coronary vasoconstriction m ay cause myocardial ischem ia and arrhythm ias.1471
Angiotensin II-stim ulated secretion o f aldosterone by the adrenal cortex and arginine
vasopressin by the posterior pituitary contributes to extra cellular volum e expansion and
sympathetic activation. 1481 O f particular relevance to the progression o f cardiovascular
disease is the recognition that angiotensin II and aldosterone exert pleiotropic effects in
the heart and systemic vasculature that result in myocardial and vascular rem odeling.1451
Important biological events include cellular hypertrophy, interstitial fibrosis, apoptosis,
inflamm ation, and thrombosis. Increasing evidence points to the RAS as a major
contributor to the progression o f atherosclerosis.1491
The key factor in the production o f angi otensin II is the enzym e ACE, and thus is
a m ajor target for therapy in cardiovascular disease. ACE, a glycoprotein widely
distributed in mammals, is a membrane-bound enzyme localized m ainly in endothelial
cells with an expression level higher in atria than in ventricles.1501 A CE is also a well
known zinc-containing carboxypeptidase’s that has a central role in blood pressure
homeostasis. 1511 ACE transforms angiotensin I into angiotensin II and degrades
bradykinin, a potent stim ulator o f the L-arginine and cyclooxygenase pathw ays.1521
Therefore, inhibitors o f ACE not only prevent the formation o f a potent vasoconstrictor
with proliferate properties but also increase local concentrations o f bradykinin and, in
turn, the production o f NO and prostacyclin.1531 The latter m ay participate in the vascular
protective effects o f ACE inhibitors by improving blood flow and preventing platelet
activation.
In clinical studies, ACE inhibitors decreased systemic vascular resistance without
an increased heart rate and prom oted natriuresis.1541 The favorable effect o f ACE
inhibition has been docum ented in m any large, random ized trials in hypertension, after
48
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m yocardial infarction, and in congestive heart failure (CHF).1551 M ore recently, ACE
inhibitors have been shown to decrease clinical events in high-risk patients with
atherosclerosis with and without ventricular dysfunction and before and after myocardial
infarction.1561 M oreover, studies have confirmed that ACE inhibitors are vascularprotective independent o f their effects on blood pressure and ventricular rem odeling.1571
The clinical effects o f ACE inhibitors in the treatment o f hypertension and CHF
underline the im portance o f neurohumoral blockade. Since the introduction o f captopril
in 1975, many long-acting m olecules have been developed.1581 D espite their clinical
efficacy, however, a substantial num ber o f hypertensive are not adequately controlled
w ith ACE inhibitors and need com bination therapy with diuretics, P-blockers, and/or
calcium antagonists.1591 Furtherm ore, clinical studies in early stages o f CHF
dem onstrated that ACE inhibitors are less effective in patients w ith high levels o f ANP,
epinephrine, and renin activity.*60*Thus, the development o f new drugs that act on
neurohumoral systems other than the RAS may be advantageous.

B. Natriuretic Peptides

The family o f natriuretic peptides consist o f three isoforms: atrial natriuretic
peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP).16' 1
Both ANP and BNP are synthesized in the atrium o f the heart under physiological
conditions and in the ventricles in the presence o f ventricular hypertrophy, and CNP in
endothelial cells.*621 ANP infusion reduces blood pressure while increasing urine volume,
urinary excretion o f sodium, and inhibits renin and aldosterone secretion,1631 and
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increases the hypotensive effect o f B N P.[64] ANP also inhibits endothelin production and
proliferation o f vascular smooth muscle cells and myocardial hypertrophy, and ANP has
been shown to have significant sympatholytic effects as w ell.[65] Because o f its biological
effect as an antagonist to angiotensin II, ANP is an endogenous inhibitor o f the RAS
(Table 4.1).'-66^ ANP and BNP production in myocardium is induced by increased atrial
pressure, as m ay occur with increased sodium intake and by decreased left ventricular
function

T able 4.1. Natriuretic Peptides H ave Contrasting Biological Effects to
A ngiotensin II.

Angiotensin II

Natriuretic Peptides

t

Blood pressure

4

4.

Renal sodium secretion

t

t

Aldosterone

4

4-

Renin secreti on

4

t

Sympathetic nerve activity

4

t

Cell proliferation

4

f

Hypertrophy

4

Circulating ANP, BNP, and CNP are quickly m etabolized and inactivated by the
specific enzym e neutral endopeptidase (N EP).[6?! The short half-life o f the natri uretic
peptides, as well as the fact that a peptide is difficult to adm inister and expensive to
produce, lim its the option o f an exogenous application o f the peptide as a possible
therapeutic strategy. It should be noted that BNP has emerged as an efficacious
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intravenous agent for the treatment o f C H F.1671 Therefore, pharm acological inhibition o f
the metabolism o f natriuretic peptides is an attractive alternative therapeutic target.

C. Neutral E ndopeptidase (NEP)

NEP is an endothelial, m em brane-bound Zn-m etallopeptidase sim ilar to ACE
that cleaves peptides at the amino side o f hydrophilic residues.1681 The m em brane-bound
metalloproteinase has a catalytic unit sim ilar to ACE. NEP is w idely distributed in
endothelial cells, sm ooth muscle cells, cardiac myocytes, renal epithelial cells, and
fibroblasts. NEP is also found in the lung, gut adrenal glands, brain, and heart.1681 It
catalyzes the degradation o f vasodilator peptides, including ANP, BNP, CNP, and
bradykinin, as well as vasoconstrictor peptides like angiotensin II.
Selective NEP inhibitors prevent, in vitro and in vivo, the degradation o f
natriuretic peptides and increase their biological activity.169*In addition to degrading
vasoactive peptides to inactive products, N EP is also involved in the enzymatic
conversion o f big endothelin to its active form, the vasoconstrictor peptide endothelinl . 1701 Certain N EP inhibitors cause vasoconstriction rather than vasodilation and infers
that vasoconstriction peptides, such as angiotensin II and endothelin-1, can be substrates
for N EP.1701 This explains why NEP inhibitors, such as candoxatril, thiorphan, and
phosphoramidon increase blood pressure in norm otensives.[71]
NEP is also involved in the m etabolism o f kinins. In m ost tissues, N EP accounts
for only a small portion o f the metabolism o f kinins, but in human cardiac tissue, NEP
accounts for nearly h a lf o f the metabolism o f bradykinin.1721 W hen ACE is inhibited,
however, NEP becom es a major pathway for bradykinin metabolism . In experimental
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studies, the reduction o f ischem ia and reperfusion dam age after NEP inhibition is kininm ediated.1731 Interestingly in hypertension, the selective NEP inhibitor candoxatril (Fig.
4.3) led to only m inim al blood pressure reduction, whereas its com bination with an ACE
inhibitor caused a marked decrease in blood pressure.1741

MeO

Figure 4.3 Structure o f Candoxatril.

D. Com bined ACE and NEP Inhibition

In m any cardiovascular diseases, an array o f regulatory m echanism s is involved,
making drugs w ith m ultiple modes o f action promising. In other words, using a single
drug for a single target is not as beneficial w hen the system has m ore than one target to
hit. Because ACE inhibition leads to normalization o f the physiological effect o f ANP
and NEP inhibitors low er blood pressure m ore effectively in salt-and-volum e-dependent
than in renin-dependent forms o f hypertension, the com bination o f ACE and NEP
inhibition m ay be especially useful in hypertension and C H F.1751 Indeed, hypertension
and CHF, the hem odynam ic and renal effects (i.e., urine volum e and sodium excretion)
achieved after sim ultaneous inhibition o f ACE and NEP are more pronounced than after
selective inhibition o f both enzymes.1751’1761
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The synergistic effect o f combined NEP and ACE inhibition is based on similar
modes o f action, including blockade o f angiotensin synthesis and simultaneous
unmasking and potentiation o f the effects o f peptides such as ANP, BNP, and bradykinin
(by preventing their degradation), in turn inducing vasodilation and diuresis and
improving m yocardial function (Fig. 4.2) ,[77]
Unfortunately, ACE and NEP structure elucidation has been a very difficult task
due to size and heavy glycosylation.1-455 At present, ACE structural inform ation is not
useful for inhibitor design, and the m ost relevant factors in inhibitor preparation remain
in knowledge o f the enzym es subtrate specificity, the use o f com puter program s to
flexibly superim pose potent conformationally restricted inhibitors (pharmacophore
development), coupled with an understanding o f the catalytic m echanism .[78] Our
understanding o f the hydrolytic mechanism o f these physiologically im portant
mammalian peptidases, and their interaction with inhibitors, has been aided greatly by
study o f the related bacterial endopeptidase therm olysin (TLN). Although the amino acid
sequence o f therm olysin is not necessarily related to the sequence o f other zinc-requiring
peptidases such as ACE and N EP,t?9J there is increasing evidence that the active sites o f
there zinc enzym es have common features.l8°E8,ri82]

such5recent X-ray structures o f

therm olysin-inhibitor com plexes have proven useful in elucidating the mode o f binding
o f related zinc peptidases including ACE and NEP.^831 M oreover, com m ercial availability
and cost makes therm olysin easier to obtain and study. Therefore, understanding
therm olysin’s m ode o f action and interaction with potential inhibitors can aid better
understanding o f ACE and NEP.
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E. Therm olysin

Therm olysin (TLN) is a thermostable zinc-containing endopeptidase o f molecular
weight 34,600 isolated from the thermophilic bacterium Bacillus therm oproteolyticus.[841
In order to understand the catalytic mechanism o f therm olysin, its crystal structure has
been determined, both in its native state and in com plexes with inhibitors.1851 TLN is
related to other peptidases such as ACE, NEP, collagenase, and enkephalinase, which
have been recognized to play important roles in cellular and horm onal m etabolism .1841 In
addition, therm olysin has proven to be an advantageous system for the detailed
evaluation o f protein-ligand binding interactions.1861
TLN is particularly suited for studying the m echanism o f zinc-prom oted peptide
hydrolysis because a variety o f crystallographic, inhibitor, substrate, and chemical
modification data are available. Importantly, the crystal and solution conformations
appear to be very sim ilar on the basis o f available experim ental com parisons,1871 and
moreover, the crystalline enzyme still hydrolyzes peptides. The relevance o f the crystal
structure is further enhanced by the fact that thermolysin changes very little upon binding
numerous inhibitors; this feature makes therm olysin a good model to study the hydrolysis
mechanism by zinc peptidases.1871
The crystal structure o f thermolysin together w ith com puter graphics analysis o f
the active site, and the x-ray structure o f a N -carboxym ethyl dipeptide inhibitor1881 have
led to a proposal o f its mechanism (Fig. 4.4).1891 The protein consists o f two spherical
domains with a deep left cleft in the middle, which constitutes the active site. In its
native state, therm olysin has a single w ater molecule bound to the zinc ion. The
inhibitor, N -(l-carboxy-3-phenylpropyl)-l-leucyl-l-tryptophan, has been observed to
54
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bind to therm olysin with the carboxyl group close to leucine interacting with zinc. In
addition, the leucyl side chain was found to be required by the active site due to its
nestled location in the hydrophobic specificity pocket.
Together w ith three ligands from the protein (Glu-166, H is-146, and H is-142), the
zinc coordination is essentially tetrahedral. An incom ing peptide is presum ed to displace
zinc bound w ater m olecule tow ard Glu-143, forming a pentacoordinate complex at Zn.
The w ater molecule, activated by the combined influence o f the metal ion and Glu-143,
attacks the carbonyl carbon to form tetrahedral intennediate. The tetrahedral
intermediate is presum ed to form a bidentate complex w ith the zinc and is stabilized, in
part, by hydrogen bonds from His-213 and Tyr-157. Glu-143 accepts the proton from the
activated w ater m olecule and is presumed to subsequently donate the proton to the
scissile nitrogen, although proton donation by solvent w ater is not excluded as an
alternative. Glu-143 is presum ed to also shuttle the rem aining proton from the hydroxyl
derived from the nucleophilic w ater molecule to the generated prim ary amine to yield the
two peptide productsJ87^
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Figure 4.4. Proposed mechanism o f therm olysin-catalyzed hydrolysis.
The reaction proceeds by the attack o f the zinc-bound w ater m olecule on
the scissile bond. The resulting tetrahedral intermediate, w ith enzyme
residues involved in its stabilization, is shown. This subsequently
decomposes to yield the products. Adapted from M atthews, the
nomenclature used for the individual amino acids (P i, Pi', etc.) o f a
substrate and the subsites (Si, S f, etc.) o f the enzym e is that o f Schechter
and Berger. A m ino acid residues o f substrates num bered P i, P 2 , etc. are
toward the N-term inal direction, and P f, P 2', etc. are toward the C-terminal
direction from the scissile bond (figure from Fernandez et al. 2001).

F. Design o f Dual ACE/NEP Inhibitors

As previously stated, both ACE and NEP are zinc M M P ’s with similar
mechanism o f actions and, hence, some structural similarities. The region o f the enzyme
where catalysis occurs are almost identical: the zinc, the zinc binding atoms, and nearby
catalytically important glutamic acid o f each enzym e could readily be superim posed on
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the corresponding atoms o f the other protease.[78i M ost relevant to inhibitor design, the
regions o f the structure w hich mimic the scissile bond o f the substrate also adopt a
common conformation. However, beyond this region, the conform ation that the inhibitor
backbone and side chains adopt is significantly different. These differences reflect the
variation in the shapes o f the binding site o f the different enzymes. These variations in
binding site topology are responsible, at least in part, for the differences in substrate
specificity. ^
ACE is a dipeptidyl carboxypeptidase usually cleaving the C-term inal dipeptide
residue o f its substrates. Potent ACE inhibitors have been designed to m im ic both di- and
tripeptides. Extensive structure activity studies o f ACE inhibitors revealed three
important structural features required for tight binding to ACE: a functional group acting
as a zinc binder, an amido carbonyl group, and a C-terminal carboxylic acid.
NEP has a broader substrate specificity than ACE and can act both as an
expopeptidase and as an endopeptidase. This behavior is reflected in the relatively large
structural variations observed with NEP inhibitors. Some potent NEP inhibitors resemble
tri- and tetrapeptides, while other smaller inhibitors are dipeptide mimics. The features
critical for an N EP inhibitor include the following: a zinc binding group, a Pi
hydrophobic group, and an amide group (or amide surrogate) available for forming two
hydrogen bonds. A term inal carboxylic acid group seems advantageous, although it is
not essential nor is its precise position as critical at it is for ACE inhibitors.
Therefore, in order for a single molecule to inhibit both A CE and NEP, it must
possess a zinc binding group. The atoms connecting this group to the rest o f the inhibitor
must be able to adopt the com m on conformation found in the zinc M M P x-ray data. In
addition, this molecule must include the functional groups required for tight binding to
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each enzyme, and these groups must be able to adopt the conform ation appropriate for
the different binding sites.
Conform ational restriction is an attractive strategy to m axim ize the binding o f an
inhibitor to a specific active site by reducing the loss o f conform ational entropy
experienced when a flexible molecule is removed from solvent and forced to fit into a
binding site.1901 However, at first glance, this approach does not appear suited for the
design o f dual inhibitors. Indeed, an inhibitor which is to efficiently occupy the binding
sites o f two structurally different enzymes cannot be totally rigid. To overcom e this
problem, a m olecule can be designed to include conformational constrained sections
designed to interact with certain areas in the binding site o f each enzyme. These
structural units can then be connected by a flexible hinge, allow ing the entire molecule to
adopt conform ations com plem entary to the active site o f each enzyme.
The active site o f an enzyme perform s the twofold function o f binding the
substrate and catalyzing the reaction. The efficiency o f these actions determ ines the
overall activity o f the enzyme towards the particular substrate, w hich in turn determines
the specificity o f the enzyme. In order for an enzyme to be selective its active site is
composed o f “sub sites,” each accommodating one amino acid residue o f the substrate.
The substrate is visualized as fitting into the groove, binding to several sub sites o f
specific geom etry (Fig. 4.5).[91]
Although NEP and ACE have significant analogies in their active sites, as shown
by their capacity to cleave in vitro identical peptides at the same b o n d J92' The selectivity
o f m olecules inhibiting these enzymes results from subtle differences in the active site o f
both peptidases. Efficient NEP inhibitors preferentially contain arom atic residues in the
Pi p o s itio n ,^ and most ACE inhibitors are characterized by a small residue (Ala) in the
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Pi position and a cyclic amino acid (Pro) in the P2 p o s i t i o n H o w e v e r , it has been
possible to design dual inhibitors o f these peptides by introducing m ore hydrophobic
residues in the selective inhibitor o f NEP and have shown relatively good affinities for
both enzym es.[94]

P o in t o f cleavage

Figure 4.5. Schem atic representation o f an enzym e-substrate complex. The active site
o f the enzym e is com posed o f 6 “subsites”, ( S 3-S 3 ), located within the catalytic site o f
the enzyme. The peptide positions, ( P 3 -P 3 ), on the peptide substrate are counted from
the point o f cleavage and thus have the same num bering as the subsites they occupy.
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Figure 4.6. Structure o f RB 105.

Recently, m ore potent dual inhibitors containing hindered substituents have been
designed giving new information about the structures o f the binding dom ains o f each
enzyme. Thus, the developm ent o f RB 105 [(2S,3R)-HSCH2C H (CH 3C H C H 3)Phe)COA la]'95' has shown that the Si o f both peptidases is able to accom m odate constrained
moieties such as a p-methylbenzyl group. However, conformational analysis o f RB 105
(Fig. 4.6) and its derivatives, to determine therm odynam ically acceptable overlaps
between stable conform ers o f these inhibitors and the ACE pharm acophore, designed
from rigid selective inhibitors, showed that the presence o f the |3-methylbenzyl group in
the P| position, precludes the presence o f bulky residues in the P2 position.'951 Recently,
a great num ber o f m olecules containing polycyclic residues at the P 2 position have been
described, showing that N EP seems to possess, like ACE, a large S2 dom ain,'951 in
agreement with earlier observations.'97' Taken together, these data support the idea that
the Si and S2 sub sites o f NEP and ACE constitute hydrophobic dom ains which could be
efficiently occupied by cyclic or linear structures.'94],'93]
Since the specificity o f ACE and NEP is essentially due to van der W alls and
ionic interactions betw een the Si , S2 , and S3 sub sites o f NEP and the Si, Si , and S2 sub
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sites o f ACE a w orking template for Pi, Pi , and P2 should be established: (1) the
substrate has to have a zinc binding group, (2) the Si pocket in both enzymes can
accommodate a large hydrophobic residue, (3) the Si sub site o f A C E and S2 sub site o f
NEP are also hydrophobic but do not seem to be as open as the S i sub site in both
enzymes, (4) although not as important as the previous three, the S2 sub site o f ACE and
the S2 sub site o f NEP favor a cyclic peptide, and (5) a terminal carboxylic acid.

G. Transition State and Enzyme Catalysis

The term transition state (TS) refers to the configuration along the reaction
coordinate that a species must pass through on its way to product formation. The
transition state corresponds to the highest energy state in the course o f a reaction; it is a
dynamic, reactive and unstable state in which bonds are only partially formed or broken.
According to transition state theory, the physical entities under consideration during a
reaction are the reagents, or ground states, and the m ost unstable species in the reaction
pathway, the transition state(s). The im portance o f transition state theory is that it relates
the rate o f a reaction to the difference in Gibbs Free Energy (G) betw een the transition
state and the ground state. This is an im portant consideration when com paring the
relative reactivity o f pairs o f substances or the rates o f a given reaction under different
sets o f conditions.
The difference in height on the energy surface between the starting materials and
the transition state is the reaction’s activation energy (or AG *), and is the energy barrier

61

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Intermediates

Black Kne = uncatalyzed
process
Red line = catalyzed
process

AG

s.m.
Prodnct(s)

Rxn Coordinate

Figure 4.7. Effect o f catalyst on reaction pathway.

that must be overcom e before the reactants can convert to product. The higher a
reaction’s activation energy is, the more difficult the path to products. An enzyme,
however, can speed up a reaction by lowering the activation energy thus providing a
smaller energy “hill” in the reaction pathway (Fig 4.6).^98] Thus, enzymes function as
catalysts in reactions, meaning that they alter the rate o f a reaction without themselves
undergoing change. The enzyme is able to function as a catalyst by converting the
substrate into a specific product through the formation o f a reactive TS. One o f the
enzymes prim ary functions in its role as a ca ta ly st, however, is not its ability to strongly
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S = substrate
ES —enzyme substr. complex
P = products
EP = enzyme prod, complex

s
p

Figure 4.8. Energy levels in catlysis vs. norm al reaction

bind the substrate or the product but rather its ability to discrim inate between substrate,
product and transition state. In 1946, Linus Pauling suggested that an enzym e binds more
strongly to the transition state than to the reactants or products.1" 1 W hen enzymes capture
the transition state, it is stabilized and as a result, less energy is needed to access this
structure. The energy barrier is subsequently lowered and the reaction is generally
accelerated - often by factors o f several orders o f magnitude (Fig. 4.8). The enzym e’s
effect is catalytic because the molecules im mediately diffuse aw ay from the active site
following product formation, enabling the enzyme to bind and transform new substrates
repeatedly.^001 To provide for the catalytic affinity, interactions between the enzyme and
the substrate are extensive with a specificity reflected in the transition stated10' 1The
binding interactions are quite numerous and can include hydrophobic, ionic, n-stacking
and hydrogen bonding.

63

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

H. Transition State Analogues

The concept o f transition state analogues has been very useful in designing potent
enzyme inhibitors .*1011 Such transition state analogues are designed on the assumption
that structures which mimic the normal transition state have optim al interactions with the
enzyme in that site. During catalysis, favorable binding interactions, not available to the
ground-state enzym e-substrate complex, develop as the enzym e-substrate transition-state
complex forms. These enhanced binding interactions assist in lowering the activation
energy o f the reaction, and hence in accelerating the enzym atic rate .*1021
TS analogue inhibitors take advantage o f these additional interactions by
possessing, in their stable structures, key structural elements o f the unstable enzymesubstrate transition-state complex.*103* Pauling predicted that it would be possible to
utilize transition state analogues as enzyme inhibitors.1*"* He predicted that, given a
reaction for which an enzyme exists, a stable substance m ight m im ic the native, reactive
transition state in shape and charge. Such a transition state analogue should bind very
tightly to the enzym e and inhibit its catalytic action by filling the binding site at its most
com plementary state, and thereby preventing the active site from binding to its true
substrate.*100*This theory has been validated over the last tw enty years, as a significant
number o f com pounds have been synthesized that behave as TS analogues in ju st the
same m anner Pauling predicted.*101* An example o f the depiction o f enzyme action is
supported by studies that show that stable mimics o f transition states (such as
phosphonates) are held tightly by enzymes that em ploy the putative mechanism (Fig
4.9).*101*In this m echanism, a phosphorus atom has been substituted for a reaction
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Transition state

stable transition state analog

Figure 4.9. Hydrolysis o f ester and phosphonate analog

carbonyl in the transition state’s tetrahedral ensemble, yielding a stable com pound known
as a phosphonate ester. The distribution o f charge on the phosphonate oxygen atoms o f
the molecule resem bles that o f the TS. In addition, the phosphorus-oxygen bonds are
about tw enty percent longer than ordinary carbon-oxygen bonds, which enables the
analogue to mimic the elongated bonds o f the T S . 1'00-1 Importantly, phosphorous esters
and amides by virtue o f their sp‘ hybridized center, closely resemble the TS achieved
during the hydrolysis o f certain carbonyl com pounds.[104] As a result, m any o f these
phosphorus-based analogues have been used as enzyme inhibitors 1' 05^11061 and as haptens
for the production o f catalytic antibodies.[100]
The arrival o f stable TS analogues, conceived to m im ic the structure o f an
intermediate in the path o f a substrate’s transformation to product, have made it possible
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to examine the degree o f enzyme binding/distortion energy, and to probe the specificity
and selectivity o f this interaction. M ost TS analogues behave as potent inhibitors
because, unlike the native substrate, they ar.e not transfonned into product and remain
tightly held in the catalytic domain, thereby inactivating the enzyme. Som e enzyme
inhibitors have been used to study the role o f individual enzymes, to understand enzyme
mechani sms, and to aid in the development o f pharm acological and agricul tural
agentsJ 107-1 A m ong them, peptides containing a transition state-analogue in place o f a
hydrolyzing amide bond have received considerable attention. Typically, peptide TS
analogues contain a phosphonoam idate or a sulfonam ide m oiety,1108] w hich show the best
resemblance to the TS during the hydrolysis o f the amide bond from both a steric and
electronic point o f view (Fig. 4.10). These TS analogues have been used in the
developm ent o f protease inhibitors such as thennolysin, renin and pepsin.

HO

O'

a

O,

O'

b

O

O

c

R = alkyl, R, = alkyl, R 2 = H, alkyl

Figure 4.10. Amide bond hydrolysis interm ediate and
two TS analogues.
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I. Phosphorus-C ontaining TS Analogues as Therm olysin Inhibitors

\\ /
^ P \
^1

^2

Phosphonate: X = O, Rj = OR, R 2 = alkyl, aryl
Phosphinate: X = O, R] = R 2 = alkyl, aryl
Phosphonamidate: X = O, X = O, R] = NHR, R 2= alkyl, aryl
Phosphoramidate: X = O, X = O, R] = NHR, R 2 = OR'

Figure 4.11. Phosphorus-containing m onoacids o f TS analogous

Some o f the m ost potent inhibitors o f therm olysin are transition state analogues
that incorporate phosphorus-containing tetrahedral groups capable o f binding to the
active site zinc in a bidentate fashion.^l09R n0l
Phosphonate, phosphinate, phosphonam idate and phosphoram idate analogues
(Fig. 4.11) designed to the same TS show different binding propensity to therm olysin.[84j
The enhanced binding and inhibitory potency o f the phosphonam idate analog has been
attributed to specific hydrogen-bonding by the am idateJ107J Grobelny and co-workers
noted that the binding energy difference was due to increased basicity o f the
phosphonam idate anion (better ligates the active zinc atom), whereas solvation effects
were negligible .^1
A well know n phosphorus-containing inhibitor used to probe the mechanism of
therm olysin is phosphoram idon [N -(a-L -rham nopyranosyloxyhydroxyphosphinyl)-L -

67

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

N
H

O

COpH

NH

R = OH

Figure 4.12. Phosphoram idon

leucyl-L-tryptophan] (Fig. 4.12). This naturally occurring potent inhibitor
(K3 = 2.8 x 10'8), consists o f a rhamnose sugar group attached to a leu-trp m oiety through
apho sp h ate.[!l2] The phosphoram idon-therm olysin complex was crystallized, and showed
monodentate Zn-ligation to one o f the phosphate oxygen’s, 2.0 angstrom s form the zinc
atom, resulting in a tetrahedral complex which closely resembles the transition state
during the catalytic process.1891 Additionally, the crystal reaffirm ed that the N-phosphoryl
group mimics a hydrated peptide since it was seen that the P -0 bonds w ere only slightly
longer than the corresponding C -0 bonds, and both the phosphoryl group and a hydrated
peptide have tetrahedral geom etries.1[87] Interestingly, removal o f the rham ose m oiety
from phosphoram idon resulted in a slightly tighter binding inhibition indicating the sugar
is not essential for thennolysin recognition.
Based on the effectiveness o f phosphoramidon as an inhibitor o f thennolysin, a
series o f related phosphoram idates and phosphonam idates have been synthesized and
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Figure 4.13. Bertenshaw’s truncated version of phosphoramidon.

proved to be potent inhibitors not only o f therm olysin, but also o f other zinc peptidases
including carboxypeptidase A, endothelin converting enzyme (ECE), and A C E.[II3]'[I14*
Bertenshaw truncated the phosphoramidon structure in an attempt to inhibit ECE (Fig.
4.13). The study found that the sugar moiety w as not essential for anti-ECE activity.*1151
Previous studies*113' also reaffirmed that the rham nose moiety was o f very little
importance for the inhibition o f ACE or ECE, whereas the phosphoryl group o f
phosphoram idon was a absolute requirement. Furtherm ore, the tryptophan residue o f
phosphoram idon appeared to be important for the ECE inhibition w hile thermolysin
inhibition seemed to depend greatly on the leucine residue. It was concluded that in vivo
ECE and therm olysin differ only in the way they recognize phosphoram idon.

J. Phosphorus Nom enclature

Phosphorus compounds can exist as di, tri, tetra, and pentavalent species. The
nomenclature o f various substituted pentavalent organophosphorus com pounds are as
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follows. A phosphate has four oxygen’s directly linked, a phosphonate has three
oxygen’s and one carbon, an H-phosphonate or phosphinate has two oxygen’s, one
carbon, and one hydrogen bonded to phosphorus. A phosphoryl is a general term
referring to solely the phosphorus-oxygen double bond (P = 0 ) w ith the term “thio” added
as a prefix when oxygen is replaced by sulfur.
It is im portant to recognize that when the four substituents around the central
phosphorus atom are different, the phosphorus becom es a chiral center. This
characteristic is im portant since it will add a chiral center in the com pound where it will
most likely ligate with the zinc atom in the metalloproteases. W ith enantioenriched
compounds tested with therm olysin new inform ation can be divulged about the
relationship o f the inhibitor and the 3D structure o f the enzymes active site.

K. a-A m inophosphonic Acid and the Pudovik Addition

The phosphorus analogs o f a-am inocarboxylic acids, a-am inophosphonic have
attracted significant attention owing to their synthetic and biological value as both
agrochemical (herbicides, pesticides, growth regulator in plants) and medicinal
(antibiotics, antivirals, enzyme inhibitors) products with broad applications.1-1161 The
bioactivity o f these com pounds is known to be strongly dependent on their absolute
configurations, and some methods, including diastereom eric1’171 and chemoenzymatic
resolutions1" 81 and asymmetric synthesis,1" 91 are available for the synthesis o f optically
pure a-am inophosphonic acids. O f the various methods for the preparation o f a aminophosphonic acids, the most general route is the Pudovik11201 addition o f
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dialkylphosphonate to a Schiff base, followed by hydrolytic or reductive cleavage o f
diester precursors to either the mono or diphosphonic acid.
The Pudovik addition is the addition o f esters o f phosphorous (III) acids with
unsaturated system s like carbonyl’s, Michael adducts, or imines producing dialkyl Nsubstituted, a-substituted, and a-am inophosphonates. The reaction is attributed to the
slow tautom erism o f the pentavalent phosphonate to the m ore reactive tricoordinate
phosphite (Fig. 4.13). The more nucleophilic tricoordinate phosphorus atom attacks the
electrophilic carbon o f the unsaturated system, forming a P-C bond, and generating a
positive charge on the phosphorus atom. A nonbonding electron pair o f the hydroxyl
group fonns a pi bond with phosphorus, neutralizing the phosphorus atom. Subsequent
proton transfer from the protonated phosphonyl to the amide anion yields the desired
products. The addition o f dimethyl phosphite to asymmetrical im ines, carbonyl’s, and
Michael adducts results in a chiral carbon bonded to phosphorus (Fig. 4.13).
Unfortunately, the addition usually produces a racemic solution due to the slow reaction
time and a reaction center that can be attacked equally on either side o f the eletrophilic
carbon (Fig. 4.13). The resulting racemic m ixture has to then be separated by either
diasteromeric or chem oenzym atic resolution.
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Figure 4.14. Dim ethyl phosphite tautomerism between pentavalent and trivalent
phosphorus. The reactive trivalent phosphorus attacks the electrophilic carbon o f
imine [1] leads the subsequent generation o f the phosphonium ion [4]. The
nonbonding electrons o f the hydroxyl group form a double bond with phosphorus to
give interm ediate [5] w hich then looses a proton to afford a-am inophosphonate
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L. A sym m etric Synthesis

The asymm etric synthesis o f organophosphorus com pounds is a relatively new
field, which has developed mostly during the past two decades.111191 For the preparation o f
enantiom erically hom ogenous molecules, chemists have basically two options. The
molecules can either be synthesized in racemic form and resolved, or the synthesis can be
performed in an enantioselective fashion so as to produce enantiom erically enriched
products. Steroselectivity in the synthesis o f chiral m olecules can be realized by
asymmetric induction o f chirality (asymmetric synthesis)'121' or via kinetic resolution.'122'
The term ‘asymm etric synthesis’ was first used in 1894 by Emil Fisher and
defined in 1904 by W. M arkwald as a reaction which produces optically active
substances from sym m etrically constituted compounds w ith the interm ediate use of
optically active materials but with exclusion o f analytical processes. M orrison and
M nsher'121' consider the asymmetric synthesis as a reaction in which an achiral unit in an
ensemble o f substrate molecules is converted by a reactant into a chiral unit in such a
manner that the steroisom eric products are formed in unequal amounts. Kagan and
F iaud'122' suggested that, “kinetic resolution can be defined as a process in which one o f
the enantiom er constituents o f a racemic mixture is more readily transform ed into a
product than the other (enantioselective reaction).” I f the Pudovik reaction is stopped
before com pletion, for example unequal amounts o f the diasterom erically substituted
organophosphorus compounds should thus be obtained. The rem aining unreacted starting
material will also exhibit optical activity.1' 23'
Pentavalent tetracoordinate organophosphorus com pounds can exist in optically
active states and are configurationally stable.'124' On the basis o f optically active
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organophosphorus compounds, syntheses o f different chiral organic com pounds have
been developed in which asymmetric induction involves; the transfer o f chirality from
phosphorus to another center, an asymmetric addition to an achiral m olecule due to
sterics or kinetics, and reactions in the course o f which the formation o f a new
stereogenic center is accompanied by elimination o f the phosphorus moiety.
Silyl phosphite esters (RO ^PO SiRN have been shown to be rem arkably versatile
phosphorylating reagents.[l25] Chiral silylated organophosphorus reagents can be used in
the asymm etric phosphorylation o f prochiral unsaturated organic substrates such as
aldehydes. One is the asymmetric variant o f the Abram ov reaction. This was applied to
compounds possessing C 2 -sym m etry where only a single stereoisom eric form exists for
the silylated organophosphorus (II) reagent and hence only two possible isomers can be
produced in the reaction with benzaldehyde.1-126^ 1271
The silylphosphite com pounds 46 have been synthesized by the reaction o f
binaphthalatochlorophosphites wR3SiOH.11281 These chiral com pounds are active
asymmetric phosphonylating reagents. They undergo the A bram ov reaction with
benzaldehyde at rt to afford new silyloxy esters 47 in high yield and with good
stereoselectivity. Silylphosphites derived from chiral (+)-dim ethyl L-tartaric esters 48 as
auxiliaries have been obtained, however, they are not sufficiently useful because they do
not react very cleanly w ith benzaldehyde (Scheme. 4 .1 )J 129^
The 2-triorganosiloxy-l,3,2-oxazaphospholidines 49 undergo the Abramov
reaction with benzaldehyde at rt to afford new esters in high yield and with good
stereoselectivity. Recrystallization o f diastereomeric m ixtures from pentane affords a siloxyphosphonate esters 50 as white crystalline solids in up to 88% isolated yield and
95% isomeric purity.[130],[ 1311 The reaction is kinetically controlled and the transfer o f the
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silyl group to the oxygen is intramolecular, w ith results in retention o f relative
configuration at the phosphorus atom (Scheme 4.2).11321

O
R 3SiOH/NEt3
(R 0 ) 2PC1 --------------------- ►
46

OSiR 3

*
PhCH O
<RO >p
(RO )2P ------ SiR 3 ----------------►
37

Ph

(R 0 ) 2P

Schem e 4.1. The Abramov reaction with binaphthalatochlorophosphites and
benzaldehyde.
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Schem e 4.2. The A bram ov reaction with 2-triorganosiloxy-l,3,2oxazaphospholidines and benzaldehyde.

The reaction o f dialkylphosphite anions with aldehydes is a m ethod for the
synthesis o f a-hydroxy phosphonamides. As stated previously, the absolute
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48

configuration at the a-position in substituted phosphonic acids is very im portant for
biological activity.
Spilling and co-workers investigated the use o f chiral phosphorus com pounds as
reagents for sym m etric synthesis, and have developed a m ethod for the asymmetric
synthesis o f a-hydroxyacid derivatives formed by addition o f chiral phosphoric acid
diamide to aldehydes. A ddition o f aldehydes to chiral phosphoric acid anions in THF
solution proceeds stereoselectively to a-hydroxyphosphonam ides 51 in good yield and
good stereoselectivity (54-93% c/e).[133] The diastereoselectivity was strongly dependent
upon the diam ide used and ranged from poor to good.[134] It was found that the reaction
proceeds irreversibly and under kinetic control. The phosphonam ides w ere hydrolyzed
with aqueous HC1 in dioxane to provide a-hydroxyphosphonic acids 52 (Schem e
4 3

)

[

1 3 4 ] , [ 1 35 ]

G ordon and Evans described the condensation o f diastereoisom eric 2-methoxy1,3,2-oxazophosphites with a variety o f aldehyde-boron trifluoride etherate complexes
resulting in diastereoisom erically enriched m ixtures o f a-hydroxy-2-oxo-1,3,2oxazaphosphorinanes 53 (75:25 diastereomeric ratio) (Scheme 4 .4 )J 132^
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Scheme 4.3. A sym m etric Pudovik addition with chiral phosphoric acid diam ide to
aldehydes.

PhCHO, Lil/BF
N aO H

Schem e 4.4. Condensation o f diastereoisomeric 2-m ethoxy-1,3,2oxazophosphites with benzaldehyde-boron trifluoride etherate com plexes.

Optically pure samples o f both enantiomers o f 55a and 55b were obtained by the
asymmetric induction method, described initially by Gilmore and M cB ride.11361 The
synthesis involved preparation o f S ch iff s bases 54 from R-(+)- and S (-)-lm ethybenzylam ine and corresponding aldehydes, addition o f diethyl phosphite,
hydrolysis, and hydrogenolysis (Scheme. 4.5). By

31
P NM R analysis o f crude esters 55

revealed that diethyl phosphite addition, when carried out at rt w ithout solvent yielded
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Schem e 4.5. Asymmetric induction method.

55a and 55b as m ixtures o f diastereoisomers formed in ratios o f 6:1. A t higher
temperatures the induction was less pronounced, e.g. heating 54 with diethyl phosphite at
140EC without catalyst, as specified by Gilmore and M cBride, produced a mixture o f
diastereoisomeric 55a and 55b in a ratio o f 2:1. M echanistic rationale for asymmetric
induction stems from the formation o f the S chiff base and sterics hindering the addition
o f diethyl phosphite on the bulky phenyl side o f the com pound (Fig. 4.15). Thus, heating
the reaction w ould provide the Schiff base with the energy needed to be in a higher
energy conform ation and leaving both sides open for attack with diethyl phosphite.
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Figure 4.15. Addition o f diethyl phosphite to the Schiff base
form ed from benzaldehyde and R-(+)-phenethylam ine. Sterics
from the phenyl ring hinder attack o f diethyl phosphate vs. the
attack on the m ethyl side.

M. a-A m inophosphonothioic Acids

Despite all o f the advances in the preparation o f enantioenriched A P A ’s, the
syntheses o f the corresponding phosphonothionate analogs o f A P A ’s, a -
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am inophosphonothioic acids, has not been as thoroughly researched. Phosphorothioic
acids are sulfur-containing analogs o f phosphate groups in nucleoside chem istry and
because the thiol group imparts chemical characteristics that differ from the

NHFh

NHR-i

thiono-tautom er

thiolo-tautom er

1: a-am inophosphonothioic acid (R = H)
2: a-am inophosphonothioate ester (R = alkyl)

Figure 4,16. General structures o f a-am inophosphonothioic acids (1) and
phosphonothioate esters (2) and their possible tautomers.

corresponding phosphate group (i.e. nucleophilicity, ligand characteristics, etc.) show
value as new substrates. Such novel properties could also be beneficial additions to TS
analogs o f enzymes. Furtherm ore, the tautomeric non-equivalent form o f the a aminophosphonothioic acids (thiono-thiolo equilibrium: Fig 4.16) and the capability to
generate a new asymmetric center at phosphorus when in the m onoester form, provides
further benefits for this class o f compounds.
The use o f Law esson’s reagent (2,4-bis(4-m ethoxyphenyl)-l,3-diathia-2,4diphosphetane-2,4-disulfide) to convert the P = 0 for P=S w ould be the most direct route
to form an APT A. Unfortunately, the preferred reactivity o f the thionating agent at the
amino or amine protecting group makes this route extrem ely difficult. Form ing the
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asymmetric APTA m onoester by displacement o f the phosphorus ester group by SFT fails
due to com peting dealkylation reactions at the phosphoais ester groups. As previously
stated, dialkyl phosphites add to imines (prepared from chiral am ines) with stereocontrol
to afford a-am inophosphonates. From previous work in this lab, it was found that
dim ethyl thiophosphite (DMTP) adds rapidly and in high yield to a variety o f
electrophiles including imines. B y adapting the DM TP addition to im ines with chiral
auxiliaries to provide the a-am inophosphonothionates bearing an enantioenriched a carbon center (Scheme 4.6) would allow direct access to the desired A PT A ’s via
hydrolysis o f the ester.

R

I
R

^ N

^ R

+

S

OMe
M eom ^S

II

►

H - ' V 0Me

'
r^

OMe

R

R = alkyl, aryl

I
n^

N

r

R

a-am inophosphonothionate

Schem e 4.6. A ddition o f dimethyl thiophosphite to chiral imines.

N. Statem ent o f the Problem

Phosphorus-containing analogues have made significant contributions to our
understanding o f TS structure, however, several drawbacks to their application (resulting
in deficits in current understanding) do remain. Some o f these draw backs include; (1) a
lack o f an essential hydrogen-bonding or solvation interaction in som e phosphonates and
phosphinates leaves then ineffectual, (2) instability to acid for m any phosphonamidates,
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and, (3) w hen used as haptens, failure to result in antibodies w ith substantial catalytic
activity suggesting that key elements in binding amidases may be absent in
phosphonam idates J 106^
D espite these drawbacks, phosphorus-containing analogues do offer useful
advantages. Certain phosphorus esters and amides, by virtue o f their sp3 hybridized
center, closely resem ble the transition state achieved during the hydrolysis o f certain
carbonyl com pounds. A nother important advantage is the use o f 3IP NM R, a sensitive
nucleus, capable o f revealing highly diagnostic chemical and biochem ical information.
In addition, x-ray techniques as in the case o f the crystal structure o f a thermolysinphosphoram idate TS analogue, has given tremendous insight into the TS-protein
interaction. Doubtless, the systematic design and use o f phosphorus-containing analogues
will remain a prom ising path toward more specific and potent inhibitors (or probes) o f
protein structure and function.
It is well established that a-am inophosphonic acids, the phosphorus analogs o f 01amino acids, exhibit novel biological properties. Substitution o f a sulfur atom in place o f
a phosphoryl oxygen forms a-am inophosphonothioic acids (A PT A ’s), a new class o f
compounds in w hich the carboxyl group o f an a-am ino acid has been replaced by a
phosphonothioic acid moiety. This alteration introduces chirality at the phosphorus
center, as observed by the tautom erically non-equivalent P[137]SH = P(S)OH
equilibrium. As a result o f this unique asymmetric center, A PT A ’s are predicted to
exhibit different chem ical properties from both a-am inophosphonic acids and the
corresponding a-am ino acids. Since a-am ino acids serve as building blocks in several
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structures im portant to biological activity, A PT A ’s could have broad applications as
amino acid mimics.
The proposed research will devise new methods for the preparation o f A PT A ’s,
use the new m ethodology to prepare peptide mimics o f the TS o f zinc M M P’s, and
prelim inary testing o f the substrates as inhibitors o f N EP and AGE.

83

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Chapter 5

Synthesis

A. Dimethyl Thiophosphite

The transform ation o f dimethyl phosphite 56 to dim ethyl thiophosphite 57 was
brought about w ith Law esson’s reagent. Law esson’s reagent acts as a thionating agent,
converting carbonyl oxygen into sulfurs.[138] The mechanism o f the reaction o f
Law esson’s reagent with carbonyl compounds is believed to occur through W ittig type
intermediates, w ith the formation o f 2,4,6-tris(p-m ethoxyphenyl)-1,3,5trioxatriphosphorinane 2,4,6-trisulfide (Fig. 5.1). Law esson’s investigation o f the
stoichiometry o f the reaction revealed that in facile reactions proceeding as low
temperatures, resulting in little loss o f Law esson’s reagent to decom position, the ratio of
0.5:1.0 reagent to reactant yields near quantitative thionation w ith attendant form ation o f
the intermediate trim er 2,4,6-tris(p-m ethoxyphenyl)-l,3,5-trioxatriphosphorinane 2,4,6-

Lawesson's reagent
Figure 5.1. L aw esson’s reagent and the known trim er 2,4,6-tris(p-m ethoxyphenyl)1,3,5-trioxatriphosphorinane 2,4,6-trisulfide form ed during thination o f carbonyls using
Lawesson’s reagent.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

o

H'

OMe

Lawesson’s reagent
Toluene, A

^

OMe
OMe

OMe

57

S chem e 5.1. Synthesis o f dimethyl thiophosphite (57) from
dim ethyl phosphite.

trisulfide, lending credibility to the proposed m echanism .[I38J The use o f Law esson’s
reagent for the thionation o f dimethyl phosphite was reported by N. Zabirov and R.
Shabana, w ith benzene and acetonitrile as the chosen solvents. Toluene was also
believed to be a suitable solvent since it is closely related to benzene but m uch less
carcinogenic. It was found that warming o f the reaction in toluene was necessary for
complete solubility o f Law esson’s reagent, or the reaction would occur in low yields.
Once com pletely dissolved, thionation o f dimethyl phosphite was nearly quantitative,
however, failure to quench the reaction im mediately resulted in overall yield reduction
(Scheme. 5.1). DBQ staining was useful in m onitoring the thionation reaction by TLC,
as neither dim ethyl phosphite nor dimethyl thiophosphite contain a strong enough
chromophore to be UV active. 2,6-D ibrom o-N-chloro-p-benzoquinoneim ine (DBQ)
reveals the presence o f a phosphorus-sulfur pi bond by producing a m aroon colored spot
after heating on TLC.
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B. Addition of DM TP to Imines Bearing Chiral Auxiliary Group

CH

SH

CH

A ddition to si face

A ddition to re face

Figure 5.2. Diastereofacial addition o f dim ethyl thiophosphite
to an aldimine.

The strategy to the stereoselective addition o f dim ethyl thiophosphite and
dimethyl phosphite to the aldimines is to distinguish between the re and si faces o f the
Schiff base (Fig 5.2). The synthesis o f the aldimines w as conducted via the condensation
o f the aldehyde (benzaldehyde, isobutyrlaldehyde, n-butyraldehyde,
phenylacetylaldehyde, and 2-methylbutyrlaldehyde) w ith the amine containing a chiral
auxiliary (phenyl glycinol, a-m ethyl benzyl amine, serine, and threonine m ethyl esters,
Scheme. 5.2). The removal o f water the reaction was necessary in order to drive the
reaction to com pletion. TLC o f the product indicated that the starting material was
consumed, however, the product Rf was inconclusive, as imines are know n to hydrolyze
upon contact with silica. It was found that the best w ay to m onitor the reactions were by
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either LC MS+ or ’H NMR. Evaporation o f the solvent followed by K ugelror distillation
afforded the desired aldimines in acceptable purity as confirm ed by the aldimine proton
near 5 8.5 ppm.
The synthesis o f dim ethyl a-am ino thiophosphonate’s from dim ethyl
thiophosphite 57 was brought about via Pudovik methodology. The aldimine was
dissolved in toluene and dim ethyl phosphite was added via syringe and stirred at rt. The
reaction was m onitored by unlocked 3IP N M R and by TLC with the aid o f DBQ resulting
in the production o f a m aroon colored spot. W hen the reaction was com plete the solvent
was evaporated and the residual oil was then analyzed by 3IP NM R to calculate the
diastereom er ratio o f the reaction (Table 5.1, Fig.5.3). Silica chrom atography o f the oil
under refined conditions led to enantioenriched dim ethyl a-am ino thiophosphonate
diasteromers (Fig 5.4). All compounds were analyzed w ith 'H (Fig 5.5) and l3C NMR.

106.3
MeO
MeCL R - 0

OH

Pv'

103.6
10

■.w—
rVfcJ

J

Figure 5.3. Exam ple o f 31P N M R spectra used to determ ine diastereom eric ratio o f
dimethyl thiophosphite or dimethyl phosphite addition.
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B

C
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Figure 5.4. 31P analysis o f the separation o f diastereom ers w ith silica
chromatography; [1], m ixture o f two diastereomers [4] and [5], separated
diastereomers after a silica column using 1% M eO H /C H C l 3 as eluent.
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OH

B

MeO

OH

Figure 5.5. A) 'H spectrum o f [1 -(2-hydroxy- l-phenyl-ethylam ino)-butyl]phosphonothioic acid 0 ,0 -d im eth y l ester. B) Example o f the posphorus
methyl ester coupling.
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Table 5.1. Addition o f dimethyl thiophosphite and dimethyl phosphite to imines
bearing a chiral auxiliary. Ratio’s were determined by 3IP NMR.
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Table 5.1. Addition of dimethyl thiophosphite and dimethyl phosphite to imines
bearing a chiral auxiliary. Ratio’s were determined by 31P NMR (continued).
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1 : 0.38

C. A sym m etric Dealkylation of Phosphorus M ethyl Esters with PEX

The m ethodology for the synthesis o f enantioenriched dim ethyl a-am ino
thiophosphonic m onoacids was based on the dealkylation o f less sterically hindered side
o f the phosphonate diester with potassium ethyl xanthate (PEX). The hypothesis was that
PEX would attack the less sterically confined ester carbon resulting in an asymmetric
dealkylation to afford enantioenriched dim ethyl a-am ino thiophosphonic monoacids (Fig.
5.6, Table. 5.2). The dimethyl a-am ino thiophosphonate’s were dissolved in acetone and
then PEX was added and stirred at rt until the reaction had completed. The progress was
monitored by unlocked 3IP N M R by following the movement o f peaks from 5 110-95 to
around S 80 ppm for P=S and from 5 30-20 to S 20-10 for P = 0 (Fig. 5.7). Once the
reaction had com e to completion the monoacids were purified and analyzed by NMR
(Fig. 5.8), then biologically tested as inhibitors o f thermolysin.

CH.
HO'

ch

3

S'

Figure 5.6. PEX attacking the less stericdally hindered methyl ester.
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Figure 5.7. 31P N M R monitoring th reaction progress o f the dealkylation o f
P=S and P = 0 with PEX.
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Table 5.2. Dealkylation o f the phosphorus methyl ester with PEX.

P roduct

%Yietd

Ratio

31p

MeO
HO,
P

=
21%
H

74:6/72.3/71.6/68.2

10:8:7:5

J
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N
H

T,

7 3.4/72,9

6''-

GO

MeO
H O .. ; .- S
3:2

'-A

72

The com pound 72, which was made from a single diasteromer, shows that
asymmetric dealkylation is possible with PEX. Since only one diasterom er was used in
the reaction you w ould expect a 1:1 ratio if both m ethyl esters were sterically equivalent.
Since the ratio is 2:3 there must be some steric bulk that is hindering PEX from attacking
one of the m ethyl esters. Although the asymmetric dealkylation o f the phosphorus
methyl ester was successful, there were some problem s w ith the isolation o f compounds
with a hydroxy functional group. The phosphonic acids with an auxiliary hydroxy group
were all followed by 31P N M R and appeared to have a successful reaction, but when
worked up the isolated products always had numerous 31P peaks in the spectrum, and
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none o f them correlated w ith the expected ppm shift. It is possible that upon purification
the hydroxy group could act as a nucleophile and form a ring with phosphorus.
Unfortunately the phosphorus acids proved to be extrem ely hard to purify due to its polar
characteristics. Reverse phase chromatography was tried but w as never very successful,
the most efficient m ethod was recrystalization with either ether or acetone, but this was
still never successful with the hydroxy compounds.

D. Conclusions

The asymm etric addition o f DM TP and DMP to imines with a chiral auxiliary
was successful. The diastereom er ratios ranged from poor (65) to good (63) and expected
considering the high reactivity o f DM TP (as compared to DM P), distance from reaction
center to asymm etric center, and w eakly stereodifferentiating system topology.
Somewhat interesting was the finding that the hydroxy group present in the chiral
auxiliary phenylglycinol had no additional effect relative to a-m ethylbenzylam ine,
whereas the presence/absence o f a hydroxy group on the amino acids did alter the
diastereoselectivity. For exam ple, changing the auxiliary from alanine to serine increased
the ratio from 61:39 to 73:27. Conversely, the use o f threonine (branching at the
hydroxyl group) as an auxiliary led to lowered diastereoselectivity possibly as the result
o f steric and conform ational limitations. Attempts to use cysteine m ethyl ester as
auxiliary to exam ine the role o f a sulfhydryl was conducted how ever the reaction with
benzaldehyde forms the tetrahydrothiazole prior to im ine formation.
It is w orthy to note that the addition o f DMTP was about 1000 fold faster than the
addition o f DMP. The faster rate o f DM TP made it possible to m ake the APTA
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precursors with imines that were not stable for a long period o f tim e plus enhancing
asymm etric addition. In the case o f DMP only imines that were stable for days could be
used in the reaction due to am ount o f time required for the reaction to com e to
completion. All o f the DMTP and DMP addition products were stable for days at room
temperature but the DM TP adducts had to be kept under Ar(g) to prevent oxidation. The
separation o f diastereom ers was achieved on some the com pounds, but a more thorough
study could be with separation with chiral HPLC columns. The asym m etric dealkylation
was accomplished w ith PEX on all o f the precursors but isolation was difficult with the
auxiliary hydroxy compounds due to side reactions during the w ork up resulting in
numerous products. It is w orthy to note that the use o f a chiral dealkylating agent may
enhance the asymmetric dealkylation o f the precursors.
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Chapter 6

Prelim inary A ssay o f a-A m inophosphonothioic Acid as Therm olysin Inhibitors

A. Kinetics

Kinetics are concerned w ith the rates o f reactions. This is a very im portant matter
for the body which maintains its steady state by adjusting reaction rates in response to the
environm ent and to hormonal controlsJ139^ Chemical reactions are classified according to
the num ber o f reactants. In the sim plest case, the first order reaction, there is just one
reactant and the rate o f the reaction is proportional to the concentration o f that reactant.
Hence, a graph o f reaction rate against reactant concentration is a straight line for a first
order chem ical reaction (Fig 6.1).[1401

Reaction
Rate. V

C oncentration of A. [A]
Figure 6.1. First Order Chemical Reaction, V vs. [A],
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In the case o f enzym e-catalyzed reactions the kinetics are not so sim ple except under
carefully chosen conditions. The course o f an enzym e-catalyzed reaction is generally
complex and enzym e reactions are usually characterized by m easuring the initial rate o f
the reaction, Vo, which is the reaction rate at time equal to zero. In a closed system, such
as a test-tube, an enzyme reaction can be started by adding the enzym e to a solution o f
the substrate and other compounds that are required for the reaction. The reaction will
start at a high rate and slow down over time for several reasons: ( 1 ) the substrate will be
used up and so the reaction rate will slow down as each enzyme m olecule spends more
time diffusing through the solution before it collides w ith a new substrate molecule, (2 )
as the reaction proceeds, product will accumulate and this may tend to inhibit the
enzyme, (3) the enzym e molecules may gradually lose activity due to random hydrolysis
or denaturation.[l40J
To sim plify the kinetics, we will start by considering only the reaction rate right at
the beginning o f the reaction, so that we do not have to worry about the three points
previously noted are not o f concern. The reaction rate at time 0, Vo is the initial slope o f
the graph o f product concentration against time (Fig. 6.2). Vo can be m easured for a
variety o f initial substrate concentrations, in order to understand how the reaction rate
will change in response to changes in substrate concentration. At very low substrate
concentrations, a graph o f reaction velocity (v) against substrate concentration will be a
straight line, like the first order chemical reaction. However, for an enzym e-catalyzed
reaction, even with only one substrate and one product, this graph will curve at higher
substrate concentrations and will level o ff at very high substrate concentration . ^ 40’ 1411
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Product
Concentration

Tone
Figure 6.2. Time Course for Enzym e Reaction

In other words: w hen the substrate is at a low concentration, it is the lim iting factor and
so an increase in substrate concentration produces a proportional increase in reaction rate.
However, as the substrate concentration increases, the enzyme concentration becomes the
limiting factor and then a further increase in substrate produces a less-than-proportional
increase in reaction rate. Eventually, the enzym e becom es “saturated” and the reaction
rate reaches a constant value that does not increase significantly as yet m ore substrate is
added. The m axim um reaction rate that is achieved is called the V max.
If the enzyme concentration is then increased, the V max will increase because there are
more enzyme m olecules available to carry out the reaction. The V maX>therefore, is only
proportional to the enzyme concentration (i.e. V max = kcat x [E] w here Kcat is a constant).
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The equation used to describe the time course o f an enzyme reaction is called the
M ichaelis-M enten equation:

v _

[S]
K * + [S 1

w here v = rate o f the enzyme
Vmax = kcat x [E] and [E] = enzym e concentration
K m = '/2 V max
[S] = substrate concentration

The M ichaelis-M enten equation can be derived from the chemical kinetics o f a very
simplified enzyme reaction with the assumption that there is only one interm ediate state,
the enzym e-substrate complex (ES). Since we are dealing w ith initial velocities it is not
necessary to consider the back reaction . [ l 41 ] Thus, the chem ical equation for an enzyme
catalyzed reaction is:

Kcat is the turnover number o f the enzyme. The turnover num ber is the num ber o f
substrate m olecules converted into product per active site at very high substrate
concentration. The velocity o f an enzyme reaction increases as [S] increases. W hen [S]
becomes m uch larger than K m the velocity approaches a constant, i.e., as [S]—>°o,
Vo—>Vmax. Hence, V max is the maximum velocity that can be achieved w ith a given total
enzyme concentration and it can be measured as the lim iting velocity obtained as [S] is
increased. Since the theory shows that V max = kcat [E] where [E] is the total enzyme
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concentration, the V max is proportional to enzyme concentration. Thus kcat is a property
o f the enzym e and its substrate and, unlike Vmax, is independent o f enzym e
concentration. The Vmax o f an enzyme is a m easure o f how fast the reaction it catalyzes
can proceed once the enzyme-substrate complex is formed.
K m is the M ichaelis-M enten constant and represents the substrate concentration
that produces h alf the m aximum velocity (Fig. 6.3). Therefore if K m is large, the whole
curve is towards the right and the reaction rate at low substrate concentration is very low
Alternatively, if the K m is small, the curve is towards the left and the reaction rate at low
substrate concentration is relatively high. If K m and kcat are known for a given enzyme,
we can use the M ichaelis-M enten equation to calculate the reaction rate, Vq.

max

K ■m

Figure 6.3. K,„ defined on a graph.
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The M ichaelis-M enten equation can be converted to a linear form by plotting
1/Vo against 1/[S] and the result is called a double reciprocal plot or a
Lineweaver-Burk plot (Fig 6.4). The plot can be used to evaluate K OT/V max and 1/Vmax
from the slope and y-intercept. The equation is:

i _ i

,

j
[S]

^ m ax

The fact that the “curve” is a straight line is a useful indicator that the M ichaelis-M enten
equation does actually describe the kinetics o f the enzym e under study.

4

9
max

i

i
Km

v

K_,
-k -------[S]

Figure 6.4. A Lineweaver-Burk plot o f 1/v vs. 1/[S]. The intercept on the
y-axis is equal to 1/Vmax and the slope is equal to K,„/Vmax.
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An alternative o f the M ichaelis-M enten equation occurs w hen v/[S] vs. v is
plotted, which is called the Eadie-Hofstee plot (Fig. 6.5). It is fitted by the equation:

max

The slope o f the graph is -1/K „„ the intercept on the v/[S] axis is Vmax/K m, and on the v
axis it is V max-

m

2

Km

v

•I * max

—

V

Figure 6.5. The Eadie-Hofstee plot o f v/[S] vs. v. The
slope is -1/K ,„, the intercept on the y-axis is V max/K m, and
the intercept on the x-axis is V max.
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The Lineweaver-Burk plot is useful for distinguishing betw een types o f inhibition. The
Eadie-Hofstee plot is better than the Lineweaver-Burk plot at picking up deviations from
the M ichaelis-M enten equation.

B. Com petitive Inhibition

If a reversible inhibitor can bind to the enzyme active site in place o f the
substrate, it is described as a "competitive inhibitor." In pure com petitive inhibition, the
inhibitor is assum ed to bind to the free enzyme but not to the enzym e-substrate (ES)
com plex . [l401 The binding is described as shown below:

E+S

ES

E|

Here Kj is the dissociation constant for the enzyme inhibitor-com plex (El). Using the
steady state theory and writing a mass balance equation that includes El along with the
enzyme and ES, an equation relating rate to substrate concentration that is analogous to
the M ichaelis-M enten is obtained. H owever K m is replaced by an apparent K m’
defined as:
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E l does not react to form E + P, and the enzyme is unable to bind both S and I at the same
time. The M ichaelis-M enten, Lineweaver-Burk, and Eadie-H ofstee equations can all be
modified to include a term that describes the inhibition by I w hen substituting K m’ for
Km
A com m on test for com petitive inhibition is to use the refined Lineweaver-Burk
and Eadie-Hofstee equations in the absence o f inhibitor and in the presence o f one or
more fixed concentration o f I. The result is a series o f lines that converge on one o f the
axes at the value o f 1/Vmax. Since the inhibitor only the effects the formation o f the ES
complex and the not the conversion o f ES to E+P, the m axim um velocity is unchanged
by the presence o f the inhibitor.^141!

C. Therm olysin Photom etric Assay

A num ber o f furylacryloyl dipeptide substrates (Fig.

6 .6 )

for the neutral proteases

have been prepared which permit the dipeptide hydrolysis to be m onitored
spectrophotometrically.^142^ The study o f therm olysin-catalyzed hydrolysis o f these
substrates has yielded kinetic inform ation o f this enzyme(kcat/K m = 2.11). The substrate
3-(2-furylacryloyl)-glycyl-L-leucine amide (FAGLA) is cleaved by therm olysin by
hydrolyzing the glycine-leucine bond (Fig.

6 .6 ).

FA G LA ’s advantage is that thermolysin

can cleave it in only one place (as shown in Figure 1), m aking the reaction specific
enough that the decrease o f substrate could be easily quantified by m easuring the
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o

N/ 'v ]j^

NH2

Therm olysin^

®

X = 345nm

Figure 6.6.
Therm olysin catalyzed proteolytic cleavage o f N-(3-[2furyl]acryloyl)-glycyl-L-leucine-am ide (FAGLA).

decrease in optical density at X = 345nm. The activity (both inhibited and uninhibited) o f
therm olysin can thus be determined using UV- Visible spectrophotom etric analysis . [1431
In other w ords, when the enzyme is not inhibited FAGLA is cleaved by the active site
and a decrease in absorbance at 345nm is observed, but when the enzym e is inhibited,
FAGLA can not be cleaved by the active site and the absorbance at 345nm stays constant
(Fig. 6.7).
Since the original assay was designed to be carried out in 1 cm cuvettes the
procedure was m odified for a micro plate reader in order to gain a higher throughput.
W hen the experim ent was changed from a 1 cm cuvette to the micro well plate reader a
drop in sensitivity o f the assay became apparent. The assay still w orked for strong
inhibitors o f thermolysin, like phosphoramidon, but not for w eak inhibitors, so the assay
was used as a screen for the panel o f compounds made in the Thom pson lab. The data
was collected and analyzed using the software Soft Max Pro and interpreted in Excel (Fig
6 .8 ,

Table 6.1)
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Figure 6.7. UV monitoring o f therm olysin substrates using FA G LA by
observing absorbance at 345nm using a micro plate reader and Soft max pro.
A) therm olysin uninhibited (decrease in 345 nm). B) therm olysin inhibited
by 70 (345nm stays constant).
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Trial 1
Sample [ s i ........... [S] corr. 1 /[S ] ’
2E-03 1.S5E-03 5 .1 7 E -0 4 .71.935
2E-04 1.55E 04 S .17E -05 19354
3E-04 2 .3 3 E - 04 7 .76 E -05 12884
5E-Q4 3.1OE-04 1.03E -04 9677
7E-04 4.65E- 04 l .S S E - 0 4 7 6451

-3 .2 6 4 0 9 : r-A2
-6 1 2 9 .3 2 0 .9 7 1 3 6
-0 .0 0 0 1 6
3.3 S E -0 4
0 .5 8 8
10............ 1.47E -06
2.50E-C6
Ki
k cat
l 2 ;8 7 i + 0 3

Slope
Y int.
Vmax
Ave Km
Bl/Ki

Trial 2 ...
Sample 1ST
2E-03 1.55E- 03
2E-04 1.55E-Q4
3E-04 2 .3 3 E -0 4
SE-04- 3.1 0 E -0 4
7E-C4 4 .6 5 E -0 4

v

:v corr.

1/v
- 1 2 2 4 4 .9
- 0I9 0 7 4 4 # # # #
- 6 6 6 6 6 .7
-1.10! # # # ■ # # #
-S 4 S 4 S .5
-1.70! # # # # # 4
- 3 5 2 9 4 .1
- 2 .3 0 # # # 4 4 4
- 2 6 0 8 7 .0
- 4.90 # # # # # #

[Ej
3 .0 7 E -0 8
3 .0 7E -08
3.07E -0S
3 .0 7 E -0 8
3 .0 7 E -0 8
A verage
Std Dev

kcap/Km
- 9 .4 7 E + 0 6
-7.70E+-06
- 8 .9 4 5 + 0 6
-8 .0 6 E + 0 6
- 8 .5 4 E + 0 6
S .06E+05

v/lS ]
-9.48E +0 3
-1.74E +0 4
-1 .42 E + 04
- 1.65E+04
- 1.48E+04

v=(kcat/Km)fE]rTl
v/[S3 = (Vmax/Km) - v * (1/Km)

Ave kcat/Km=
-5 .3 3 E + 0 6
s t d e v kcat/Km= 4 .65E + 06
Ave Ki4 .3 5 E -0 6

£S ] corr. . l / C S ] ’ v

v corr.
1 /v
S.17E -04
- 1 4 2 8 5 .7
1935 - 4 .2 0 ! # # # # # #
S .17E -05 19354
7 . 7 6 E 0 5 12884
1.03E -04 9677 - 1 .5 0 # # # # # #
- 40 0 00 .0
1.5SF-04 6451 :2i00! # # # # # # ; - 3 0 0 0 0 .0

kcap'Km
[ E f .......
3.07E -08

v / r s ]7

-8.13E +03

3.0 7 E -0 8 -7 .8 9 E + 0 6 - 1.45E+04
3.07E -0S -7 .0 1 E + 0 6 - 1.29E+04
Average -7 .4 S E + 0 6
Std Dev
6.20E + 05

- 3 .3 3 1 7 1 rA2 .. 7 .1.
Slope
- 8 0 3 4 .0 8
0 .9 9 9
Y int
-1.2 4E 04
Vmax
Ave Km 3 .3 5 E -0 4
0 .2 3 6
[13/Ki
1.47E -06
[I]......
6 .2 0 E -0 6
Ki
- 2 .50E + 03
k cat

Figure 6.8. D ata im ported into Excel from Soft M ax Pro and put into the EadieHofstee equation to help calculate average K; o f 70.
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Table 6.1. Kj values o f substrates tested on therm olysin using
FAG LA and a micorwell plate reader

Substrate

K { (mM)

MeO
HO.„
S
P"

z
4.28

' ’’"‘- r ' T ' ' ' n
H H

a

1
'"-'-A'''

MeO
HO,,1p^ , S
.A

_
1.69

^

G N
H H

MeO
HO,, > .,-0
P'-

4

r

LA A
^

i N'
H H

■{ •''" A ;

4.18

A.

Although the results did not show substantial inhibition o f therm olysin they did
show partial inhibition. This w as not to much o f a surprise since the com pounds tested

did not have carboxylic acid functional group which has been proven to help guide the
peptide into the active site. But the prelim inary results show that there is some
coordination to the active site suggesting that the P=S and P = 0 can coordinate w ith the
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zinc atom w ithin the site. To help bind the inhibitor an additional peptides may be added
in order to fill more S pockets o f the enzyme. Plus, resolving the diastereom ers and
testing them separate would most likely lead to a higher inhibition since the substrates
would not be com peting with its diastereomer for the active site.
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Chapter 7

Conclusions

A. Synthesis and Testing o f APTA Compounds

In conclusion, DM TP adds with good diastereoselectivity to imines containing Nchiral auxiliaries. Using readily available chiral amines, a-am inophosphonothionates
may be prepared in good yield and high stereoselectivity. U sing these findings, the
synthesis o f A PT A ’s containing a P-chiral group will be possible. The asymmetric
dealkylation o f the phosporus methyl esters was accomplished w ith PEX, but the use o f a
chiral nucleophile m ay em phasize asymmetric attack by capitalizing on the sterics o f the
methyl ester and should be explored.
Adapting the therm olysin assay for the m icro plate reader was accomplished, but
it only showed strong inhibition and can only be used for prelim inary results. The main
problem with the assay was the background noise was often to high and would make the
subtle drop in absorbance difficult to quantify. W ork is being done on developing a MS
assay using single ion m onitoring and should prove to be a better assay.
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Chapter 8

Future W ork

A. Building a Tripeptide M imic
Since the S and S ’ pockets o f ACE have been elucidated it is known that there are
three prim ary sites that guide and hold the peptide in the active site. It would then seem
prudent to m atch a peptide for each pocket o f the enzyme. In other words, if there are
three subsites in the enzym e than the inhibitor should have three peptides to fully exploit
its inhibitive properties. Thus, the dipeptides that have been m ade in this study could be
improved with the addition o f another peptide.
Initial attempts to functionalize the hydroxyl group o f the a am inophsphonothioates with phenyl glycinol, serine methyl ester, and threonine methyl
ester (63, 67, and 69) were unsuccessful but had interesting results. The M itsunobu
reaction with triphenylphosphine and diethyl azodicarboxylate resulted in the oxidation
o f the hydroxy unit to an aldehyde. Although it was not the expected outcome, the
aldehyde could provide some interesting synthetic routes. Follow ing dealkylation o f the
phosphorus ester an imine could be made which could be attacked by sulfur to form a
mechanistic transition state adduct (Fig. 7.1).
A third amino acid could also be coupled with the phosphonic monoacid via a
DCC coupling reaction. Once the tripetide is made by the coupling o f an amine with the
phosphonic acid a second dealkylation would provide a TS analog that has the zinc
binding group incorporated into the peptide framework which w ould mimic the
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angiotensin enzym e m ore closely than the dipeptide with the zinc binding group in the
terminal position (Fig 7.2).

1. PPh3, THF

Me»e?„S

P

0°C

OMe

OMe

2. EtO"U'N 'NV OEt
O
JHO „ H

M e O .^ S

Me55®2*S H
OMe

.0

PEX

OMe

O

HO „ h

MeO „
1.S

M eO .o^S n

0=P

RNHn

R
NH

OMe

OMe

O

Figure 7.1. M itsunobu reaction and possible route to mechanistic
transition state inhibitor.
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Figure 7.2. APT A coupling with DCC and an amine followed by dealkylation
with PEX to afford a tripeptide transition state inhibitor.
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Chapter 9

Experim ental

A. iso-Polydiacetylene Compounds

Unless otherwise noted, reactions were run in flam e-dried apparatus under argon
atmosphere.

Anhydrous reagent grade solvents (CH 2 CI2 ; THF; toluene; CH 3OH;

benzene) were purchased from Aldrich Chemical Co. in sure sealed bottles and used
without

further

purification.

Protected

amino

acids,

phenyl

glycinol,

a-

methylbenzylam ine, isobutyryl chloride, isobutyryl aldehyde, cyclohexanecarbonyl
chloride, trim ethyl phosphite, 3-methyl-butyraldehyde, phenyl-acetaldehyde, Pd(PPfi 3),
Cul, TEA, diisopropyl ethyl amine, t-butyl alcohol, and law esson’s reagent were
purchased from Aldrich Chemical Co. and used without further purification,

bis-

Trimethylsilyl acetylene was purchased from Petrarch and used w ithout further
purification.

Analytical thin-layer chromatography (TLC) was perform ed on silica gel

(W hatman) aluminum -backed plates. Flash chromatography was perform ed with silica
gel (Merck, 230-240 mesh).

Compounds were detected using a U V lamp at 254 nm

and/or stained with ninhydrin or 2,6-dibromoquinone-chlorim ide. Yields are optimized.
'H NM R (400 M Hz), 13C NM R (100 MHz), 31P N M R (171 M Hz) spectra were
determined on a Varian 400 M Hz Unity Plus spectrometer. Chem ical shifts are reported
in parts per m illion (ppm, 5) using CHCI 3 (7.26 ppm for 'H), CD CI 3 (77 ppm for

13C)

or

85% H 3PO 4 (0 ppm for 3 IP). as references. High resolution m ass spectra (HRM S) were
obtained using electrospray ionization (ESI) M icromass LCT connected w ith w ater 2790
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HPLC w ith C-18 reversed phase column (2.1 mm i.d., 5 cm long). Elemental analyses
for C, H, and N w ere performed by M idwest M icrolab, Indianapolis, IN. All the HRMS
and elemental analyses o f the novel compounds are w ithin acceptable error range.
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B. com pounds 22-45

CHC10

-€

l-T rim ethylsilanyl-4-m ethyl-pent-l-yn-3-one (22). In a flask was placed CH 2 CI2 (100
mL), bis(trim ethylsilyl)acetylene (10.24 g; 60.0 m m ol), and isobutyryl chloride (6.36 g;
60.0 mmol) and reduced temperature to 0 EC with an acetone/ice bath. To this was
added AICI3 (8.00 g; 60.0 mmol) and let contents stir at ambient tem perature for 6.0 h.
The reaction changed from a cloudy opaque color to a cloudy dark amber. The reaction
was then concentrated in vacuo resulting in a dark red oil. The oil was diluted with
EtOAc (50 mL) and then poured into a beaker w ith ice-cold 10% EIC1 (150 mL)
transm uting the dark am ber color to bright yellow. The reaction was extracted with
EtOAc (3x100 mL) followed by extraction o f the organic phase with H 2 O, sat. N aH C 0 3,
and brine. The organic phase was then dried over anhydrous N a 2 SC>4 for 0.5 h and
concentrated in vacuo resulting in dark red oil. Com pound 22 (8.98 g; 53.4 mm ol; 89 %)
was isolated as a colorless oil after distillation at 43 EC at 0.25 mmHg.

'H N M R (C D C 1 3, 400 MHz): 5 2.50-2.57 (m, J = 7.1 Hz, 1H), 1.09 (d, 7 = 7.1 Hz,
0.15 (s, 9H);
,3C NM R (CDCI 3 , 100 MHz): 5 192.6, 102.0, 99.5, 43.7, 18.8, 0.2.
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6

H),

CHC1-

l-cyclohexyl-3-trim ethyIsiIanyI-propyn-l-one (31). To a flask was added C H 2 CI2 (100
mL), bis(trim ethylsilyl)acetylene (5.12 g; 30.0 m m ol), and cyclohexanecarboxylic acid
chloride (4.39 g; 30.0 mmol). The temperature was brought to 0 EC with an acetone/ice
bath, and AICI 3 (4.00 g; 30.0 mmol) was added and let stir at am bient tem perature for

6 .0

h. The reaction m ixture changed from a cloudy opaque color to a cloudy dark amber
during this period. The reaction mixture was then concentrated in vacuo resulting in a
dark red oil. The oil was diluted with EtOAc (50 mL) and poured into a beaker that
contained iced 10% HC1 (150 mL) transmuting the dark am ber color to bright yellow.
The reaction m ixture was separated, extracted with EtOAc (3x100 mL) followed by
extraction o f the organic phase with H 2 O, sat. NaHCCL, and brine. The organic phase
was then dried over anhydrous N a 2 S 0 4 for 0.5 h and then concentrated in vacuo resulting
in dark red oil. Compound 31 (3.88 g; 18.62 mmol; 62 %) was isolated as a colorless oil
after distillation at 76 EC at 0.25 mmHg. Anal. Calcd for: C ^ H ^ O S i: C, 71.24; H,
6.97; Found: C, 71.04; H, 7.01.

'H NM R (CDCI 3 , 400 MHz): 5 2.36-2.48 (m, J = 3.8 Hz, 1 H), 2.00-1.96 ( m , J = 3.8 Hz,
2 H), 1.81-1.77 ( m , J = 3.8 Hz, 2 H), 1.68-1.65 (m, J = 3.8 Hz, 1 H), 1.46-1.19 (m, J =
3.8 Hz, 5 H ), 0.18 (s, 9 H);
13C N M R (CDCI 3 , 100 MHz):

8

192.4, 1 0 2 .5 ,9 9 .5 ,5 3 .1 ,2 9 .2 , 2 6 .8 ,2 6 .4 ,0 .4 .
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2-m ethyl-l-trim ethylsilanylethynyl-propenyl trifluorom ethanesulfonate (32). To a
100 ml RB flask was added CH 2 C12 (50 mL), 2,6-di-tert-butyl-4-m ethylpyridine (1.33 g;
6.5 mmol), and 22 (1.00 g; 6.0 mmol). It was then cooled to -7 8 EC under Ar (g).
Triflouromethane sulfonic acid (2.01 g; 7.20 mm ol) was added via syringe and then the
reaction was w arm ed to rt while stirring. After 8.0 h the reaction had turned to a dark
brown color and was concentrated in vacuo resulting in a chunky brow n salt. Pentane
(100 mL) was added to the brow n precipitate and the insoluble triflate/2,6-di-tert-butyl-4methylpyridine salt was gravity filtered. The brown organic layer was then extracted
with iced 10% HC1, H 2 0 , sat. N aH C 0 3, brine, and dried over N a 2 SC>4 . The solution was
then concentrated in vacuo to afford dark brow n oil. The oil was distilled at 0.25 mmHg
and 65 EC resulting in a clear colorless oil (1.41 g; 4.69 mmol; 78%).

'H N M R (CDC13, 400 MHz): 5 1.98 (s, 3 H), 1.91 (s, 3 H), 0.21 (s, 9 H);
13C N M R (C D C 13, 100 MHz): 5 138.6, 127.7, 119.0(q, J = 320 Hz), 1 0 1 .2 ,9 5 .5 ,2 2 .1 ,
19.6,0.48.
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l-C yclohexylidene-3-trim ethylsilanyl-prop-2-ynyl trifluorom ethanesulfonate (33).
l-cyclohexyl-3-trim ethylsilanyl-propyn-l-one (5.41 g; 26.0 m m ol) and 2,6-di-/erf-butyl4-methylpyridine (6.42 g; 31.3 mmol) in CH 2 CI2 (225 mL) was chilled to -7 8 EC and
triflourom ethane sulfonic acid (8.62 g; 5.14 ml; 30.5 mm ol,) w as added dropwise via
syringe. The reaction was warmed to rt after 0.5 h and at 8.0 h the reaction had turned to
a dark brow n color. The reaction concentrated in vacuo resulting in a chunky brown
solid. Pentane (100 mL) was added to the brown precipitate and the insoluble triflate/2,6di-tert-butyl-4-m ethylpyridine salt was gravity filtered. The brow n organic layer was
then extracted w ith iced 10% HC1, H 2 0 , sat. NaHCCL, brine, and dried over N a 2 S 0 4 .
Evaporation in vacuo followed by flash chrom atography with hexanes gave 33 as clear
yellow oil (6.55 g; 19.2 mmol; 74%).

'H NM R (CDCI 3 , 400 MHz): 5 2.42-2.34 (m, J = 6.3 Hz, 4 H), 1.68-1.58 (m, J = 6.3 Hz,
6

H), 0.21 (s, 9 H );

I3 C N M R (C D C 13, 100 M Hz):

6

146.1, 127.7, 119.0 (q, J = 320 Hz), 101.2, 95.5,31.2,

28.6,27.0, 26.6 ,2 5 .7 , 0.48.
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0 .0 1M B orax
MeOH, rt

l-cycIohexyl-2-propyn-l-one (34).

To a 100 mL RB flask was added M eOH (35 mL),

0.01 M Borax (3.9 mL), and l-cyclohexyl-3-trim ethylsilanyl-propyn-l-one (500 mg, 2.40
mmol). The reaction was stirred at rt for 12 h and the m ixture changed from colorless to
pale yellow. The reaction was then quenched at 0 EC w ith iced 10% HC1 (50 mL). The
solution was extracted w ith hexanes (3 x 30 mL). The organic layers were combined and
extracted with sat. N aH C 0 3 and dried over Na 2 S 0 4 for 15 min. The organic layer was
then filtered and concentrated in vacuo to afford a crude yellow oil. The yellow oil was
then distilled at 0.25 m m H g and 49 EC to afford 34 (0.286 ;, 2.10 m m ol ; 87%). Anal.
Calcd for: C 9H 12O: C, 79.37; H, 8 .8 8 ; Found: C, 79.45; H, 8.64.

'H N M R (C D C b, 400 MHz):

6

3.23 (s, 1 H), 2.36-2.48 (m, J = 3.8 Hz, 1 H), 1.99-1.95

(m, .7 = 3.8 Hz, 2 H), 1.78-1.75 (m, J = 3.8 Hz, 2 H), 1.65-1.63 (m, ,7 = 3.8 Hz, 1 H),
1.45-1.14 (m, J = 3.8 Hz, 5 H);
13C N M R (CDCI 3 , 100 M Hz):

8

191.7, 80.7, 78.9, 52.1, 27.8, 25.6, 25.2.
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Pd(PPh3)4, Cul

l-C ycIohexyl-4-isopropylidene-6-trim ethylsilyl-2,5-hexyne-l-one (35). To a 100 mL
RB 3 neck flask containing anhydrous benzene (15 mL), 32 (2.00 g; 6.64 mmol), Hunig’s
base (2.52 g; 2.4 mL; 9.92 mmol), Pd(PPh 3)4 (168 mg; 0.14 mmol, 2.2 mol%), and Cul
(6

mg; 0.0026 mm ol) was degassed with Ar (g) for 0.75 h. To this solution was added,

via syringe pump at 0.01 mL/min, 34 (1.32 g; 9.71 mmol) dissolved in anhydrous
benzene (3 mL). W hen the addition was complete the reaction was diluted with
Et 2 0 :Hex (1:1) (100 mL) and then extracted with 10% aqueous HC1. The combined
aqueous layers were back extracted with Et 2 0 :Hex (1:1) (2 x 30 mL) followed by
extraction o f the organic layer with H 2 O, aqueous NaHCCL, brine, and dried over MgSCfl
for 0.5 h. The solution was gravity filtered and concentrated in vacuo to afford dark
brown oil. 35 (1.084 g; 3.86 mmol, 58%) was isolated after flash chrom atography with
silica and 0.3% EtOAc/hex (5 L) as yellow oil. Anal. Calcd for: C igH ^O Si: C, 75.46; H,
9.15; Found: C, 75.51; H, 9.03.

'H NM R (CDCI 3 , 400 MHz): 5 2.39-2.46 (m, J = 3.9 Hz, 1 H), 2.08 (s, 3 H), 2.06 (s, 3
H), 2.00-1.96 (m, J = 3.2 Hz, 2 H), 1.79-1.74 (m, J = 3.9 Hz, 2 H), 1.65-1.61 (m, J = 3.9
Hz, 1 H), 1.49-1.14 (m, J = 3.2 Hz, 5 H) 0.19 (s, 9 H);
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13C N M R (CDCI 3 , 100 MHz): 5 192.4, 163.5, 101.4, 100.8, 98.8, 90.6, 89.7, 53.4, 29.4,
26.9, 26.5 ,2 4 .4 , 24.3,0.9.
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TMS/OTf
TMSO

OTMS
-78 °C

2-m ethyl-3-[l,3]dixolane-l-trim ethylsilyl-l-pentyne (36). To a 100 mL RB flask was
added CH 2 CI2 (25 mL) and trimethylsilyl trifluorom ethanesulfonate (11.3 mg; 9.0 pL;
0.05 mmol) at -7 8 EC. To this solution was added l,2-bis(trim ethylsilyloxy)ethane (1.05
g; 1.25 mL; 5.10 m m ol) and 4-m ethyl-l-trim ethylsilanyl-pent-l-yn-3-one (0.840 g; 5.00
mmol) and stirred at -7 8 EC for 1.0 h. The reaction was warmed to rt and after 13 h the
color had changed from colorless to a dark amber. Anhydrous pyridine (5.0 pL) was
added via syringe and then stirred for 1.0 h. The reaction was then transferred to a
seperatory funnel and extracted with aqueous N a 2 SC>4 and CH 2 C12 (3 x 40 mL). The
organic layers w ere combined and dried over N a 2 S 0 4 followed by evaporation in vacuo
to afford dark am ber oil. The oil was distilled to yield 36 (0.917 g; 4.32 mm ol, 87%).
Anal. Calcd for: C n H 2o 0 2 Si: C, 62.21; H, 9.49; Found: C, 62.03; H, 9.33.

'H NM R (CDCI 3 , 400 MHz): 5 4.12-4.09 (m, J = 3.8 Hz, 2 H), 3.99-3.96 (m, J = 3.8 Hz,
2 H), 1.99 (m, J = 6.4 H z,l H), 1.06 (d, J = 6.4 Hz,

6

H), 0.18 (s, 9 H);

13C N M R (CDCI 3 , 100 MHz): 5 107.4, 102.7, 90.2, 65.9, 37.6, 18.2, 0.9.

124

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

rA

0

r

TMSO

TMS/OTf

a

OTMS

TMS

O.

.0

CH2CI2

TMS

-78 °C

l-cyclohexyI-l-[l,3]dioxolane-3-trim ethylsiIyl-2propyn-l-one (37). A 100 ml RB
flask, purged with Ar(g), containing CH 2 CI2 (25 mL) and trim ethylsilyl
trifluorom ethanesulfonate (11.3 mg; 9.0 pL; 0.05 mm ol) was cooled down to -7 8 EC.
To this solution was added l,2-bis(trim ethylsilyloxy)ethane (1.05 g; 1.25 mL; 5.10
mmol) and 4-m ethyl-l-trim ethylsilanyl-pent-l-yn-3-one (1.04 g; 5.00 mmol) and stirred
at -7 8 EC for 1 h. The reaction was warmed to rt and after 13 h the color had changed
from colorless to a dark amber. Anhydrous pyridine (5.0 pL) was added via syringe and
then stirred for 1 h. The reaction was then transferred to a seperatory funnel and
extracted with aqueous N a 2 S 0 4 and CH 2 CI2 (3 x 40 mL). The organic layers were
combined and dried over Na 2 S 0 4 followed by evaporation in vacuo to afford dark amber
oil. The oil was distilled to yield 37

(866

mg; 3.43 mmol,

68

%). Anal. Calcd for:

C , 4H 2 4 0 2 Si: C, 66.61; H, 9.58 C, 66.61; H, 9.58; Found: C, 66.05; H, 9.52.

'H NM R (CDCI 3 , 400 MHz):

6

4.12-4.08 (m, J = 3.8 Hz, 2 H), 3.96-3.92 (m, 7 = 3 .8 Hz,

2 H), 2.10-1.21 (m, 11 H), 0.18 (s, 9 H);
13C N M R (CDCfl, 100 MHz):

6

106.6, 103.1, 90.3, 65.7, 47.1, 28.2, 27.3, 26.9, 0.9.
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M eOH

2-m ethyl-3-[l,3]dixolane-l-pentyne (38). To a 100 mL RB flask was added 35 ml
MeOH (35 mL), K 2 CO 3 (1.0 g, 7.23 mmol), and 37 (500 mg, 2.35 mmol). The reaction
was stirred at rt for 2.0 h where the solution changed from colorless to pale yellow. The
reaction was then quenched at 0 EC with iced 10% HC1 (50 mL). The solution was
extracted with hexanes (3 x 30 mL). The organic layers w ere com bined and extracted
with sat. N aH C 0 3 and dried over N a 2 S 0 4 for 15 min. The organic layer was then filtered
and concentrated in vacuo to afford a crude yellow oil that had the smell o f pine. The
yellow oil was then distilled at 0.25 mmHg at rt to afford 38 (0.275 g, 1.95 mm ol ; 83%).

'H NMR (CDCI 3 , 400 MHz): 5 4.12-4.09 (m, 7 = 3.8 Hz, 2 H), 3.99-3.96 (m, 7 = 3.8 Hz,
2 H ) ,2.51 (s, 1 H), 1.95 (m, 7 = 6 .4 H z,l H), 1.06 ( d ,7 = 6 .4 Hz,

6

H);

13C NMR (CDCI 3 , 100 M Hz): 5 106.6, 102.1, 82.2, 65.0, 36.6, 18.4.
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n

r

a

Pd(PPh3)4
TEA
Cul

OTf

n

r~ \

Ov n

•TMS

TMS

H

2-M ethyl6-cyclohexylidene-3-[l,3]dioxane-2-M ethyI-6-trim ethylsilyl-4,7-heptyne
(39. )To a 100 mL RB 3 neck flask containing anhydrous benzene (15 mL), 33 (2.00 g;
5.87 mmol), TEA (0.89 g; 1.23 mL; 8.77 mmol), Pd(PPh 3) 4 (148 mg; 0.12 mmol, 2.2
mol%), and Cul

(6

mg; 0.0026 mmol) was degassed w ith A r (g) for 0.75 h. To this

solution was added, via syringe pump at 0.01 mL/min, 38 (1.20 g; 8.58 mm ol) dissolved
in anhydrous benzene (3 mL). W hen the addition was com plete the reaction was diluted
with Et2 0 :Hex (1:1) (100 mL) and then extracted with 10% aqueous HC1. The combined
aqueous layers were back extracted with Et 2 0 :Hex (1:1) (2 x 30 mL) followed by
extraction o f the organic layer with EI2 O, aqueous N aH C 0 3, brine, and dried over M g S 0 4
for 0.5 h. The solution was gravity filtered and concentrated in vcicuo to afford dark
brown oil. 39 (0.87 g; 2.64 mmol, 45%) was isolated after flash chrom atography with
silica and 0.3% EtOAc/hex (3 L) as yellow oil.

'H NM R (CDCfj, 400 M Hz):

8

4.11-4.09 (m, J = 3.8 Hz, 2 H), 3.98-3.97 (m, J = 3.8 Hz,

2 H), 2.02-1.98 (m , J = 3.8 Hz, 4 H), 1.96-1.93 (m, J = 6.4 H z,l H), 1.83-1.46 (m, .7=3.8
Hz,

6

H) 1.06 (d, J = 6.4 Hz,

6

H);

13C NMR (CDC13, 100 M Hz): 5 157.1, 107.3, 101.9, 97.4, 89.3, 82.4, 65.6, 47.3, 28.3,
27.3,26.9, 23.8, 1.0.
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o

o
TMS

KF

H

CH3CN

l-C yclohexyl-4-isopropylidene-6-trim ethylsiIyI-2,5-bexyne-l-one (42). 35 (1.00 g;
3.57 mmol) and KF (230 mg; 3.96 mmol) was put in a 250 mL RB flask containing
CH 3 CN (100 mL) and stirred at rt for 48 h. The reaction was then concentrated in
followed by dilution with EtOAc (100 mL). The solution was then extracted with sat.
NaHCCL (aq), H 2 O, and brine. The organic layer was dried over N a 2 S 0 4 for 0.5 h,
gravity filtered, and then concentrated in vacuo leaving yellow oil. The oil was
chromatographed with silica and hex:EtOAc (99:1) to afford 42 (680 mg; 3.17 mmol;
91%). Anal. Calcd for: C i 5H , 8 0 : C, 84.07; H, 8.47; Found: C83.92; H, 8.81.

‘H N M R (CDCI3 , 400 MHz): 5 3.12 (s, 1 H), 2.42-2.34 (m, J = 3.9 Hz, 1 H), 2.10 (s, 3
H), 2.05 (s, 3 H ) 1.96-1.93 (m, J = 2.6 Hz, 2 H), 1.76-1.72 (m, 7 = 3.9 Hz, 2 H), 1.631.60 (m, J = 3.9 Hz, 1 H) 1.44-1.151 (m, J = 2.6 Hz, 5 H);
l3C N M R (CDCI3 , 100 MHz):

8

192.2,164.3, 99.1, 89.5, 88.0, 81.5, 80.4, 78.7, 53.3,

29.3, 26.8, 26.4, 24.3.
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l-CycIohexyI-7-cyclohexylidene-4-isopropylidene-9-trim ethylsiIanyI-nona-2,5,8triyn -l-on e (43). A 100 mL 3 neck flask containing benzene (40 mL), trifluoromethanesulfonic acid l-cyclohexylidene-3-trim ethylsilanyl-prop-2-ynyl ester (5.416 g;
15.9 m m ol), H unig’s base (6.03 g; 5.7 mL; 46.6 mmol), Pd(PPh 3)4 (349 mg; 0.30 mmol;
2.2 mol% ), and Cul (15 mg; 0.0079 mmol) was degassed with A r (g) for 45 min. To this
solution was added, via syringe pum p at 0.01 mL/min, l-Cyclohexyl-4-ethynyl-5-m ethylhex-4-en-2-yn-l-one (5.02 g; 17.13 mmol) dissolved in benzene (5 mL). W hen the
addition was complete the reaction was diluted with Et 2 0 :H ex (1:1) (100 mL) and gravity
filtered. The filtrate was extracted with 10% aqueous HC1 (3 x 100 mL) and combined
aqueous layers were back extracted with Et 2 0 :h ex (1:1) (2 x 30 mL) followed by
extraction o f the organic layer with H 2 0 , aqueous NaHCCfi, and brine. The organic layer
was then dried over MgSCfi for 0.5 h and then concentrated in vacuo to afford dark
brown oil. 43 was isolated after flash chromatography w ith silica and 5 L o f 0.6%
EtOAc/hex as yellow oil (3.73 g; 9.31 mmol; 59%).

'H N M R (CDC13, 400 MHz):

8

2.52-2.40 (m, 5 H), 2.10 (s, 3 H), 2.09 (s, 3 H), 2.00-1.18

(m, 16 H), 0.18 (s, 9 H );
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I3C NM R (CDCI 3 , 100 M Hz):

8

192.4, 163.3, 161.8, 102.1, 101.4, 9 9 .1 ,9 7 .2 ,9 0 .3 ,9 0 .2 ,

87.8, 53.4, 33.9, 33.8, 29.4, 28.6, 27.2, 26.9, 26.5, 24.3, 1.0.
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l-C ycIohexyl-7-cycIohexylidene-4-isopropylidene-nona-2,5,8-triyn-l-one (44). 43
(3.73 g; 9.37 m m ol) and KF (600 mg; 10.3 mmol) were put in a 500 m L RB flask
containing CH 3 CN (250 mL) and stirred at rt for 168 h. The reaction was then
concentrated in vacuo followed by dilution with EtOAc (100 mL). The solution was
extracted with sat. N aH C 0 3 (aq), H 2 O, and brine. The organic layer w as dried over
Na 2 S 0 4 for 0.5 h, gravity filtered, and then concentrated in vacuo to afford yellow oil.
The oil was chrom atographed with silica and hex:EtO Ac (99:1) to yield l-Cyclohexyl-7cyclohexylidene-4-isopropylidene-nona-2,5,8-triyn-l-one as yellow oil (2.62 g; 7.88
mmol; 84%).
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Pd(PPh3)4, Cul

1-C yclohexyl-7-cycIohexylidene-4,l O-isopropylidene-12-trim ethylsilanyl-2,5,8,l 1dodecyn-l-one (45). A 100 mL 3 neck flask containing benzene (40 m L), trifluoromethanesulfonic acid 2-methyl-1-trimethylsilanylethynyl-propenyl ester (4.12 g; 13.7
mmol), H unig’s base (6.81 g; 6.5 mL; 53.9 m m ol), Pd(PPh 3) 4 (454 mg; 0.394 mmol; 2.2
mol%), and Cul (18 mg; 0.095 mmol) was degassed with Ar (g) for 0.75 h. To this
solution was added, via syringe pump at 0.01 mL/min, l-C yclohexyl-7-cyclohexylidene4-isopropylidene-nona-2,5,8-triyn-l-one (3.57 g; 15.1 mmol) dissolved in benzene (5
mL). W hen the addition was complete the reaction was diluted with Et 2 0 :Hex (1:1) (100
mL) and gravity filtered. The filtrate was extracted with 10% aqueous HC1 (3 x 100 mL)
and the com bined aqueous layers were extracted with Et 2 0 :H ex (1:1) (2 x 30 mL)
followed by extraction o f the organic layer with H 2 0 , aqueous N a H C 0 3, and brine. The
organic layer was dried over M g S 0 4 for 0.5 h and then concentrated in vacuo to afford
dark brown oil. 45 was isolated after flash chrom atography with silica and 5 L o f 0.6%
EtOAc/hex as orange oil (2.38 g; 4.93 mmol; 36%). HRMS calcd for M +H + o f
C 33H 42OSi 483.3083, found 483.3067.
132

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

'H NMR

(C D C I3,

400 MHz): 5 2.52-2.37 (m, 5H), 2.10 (s, 3H), 2.08 (s, 3H), 2.02 (s

3H), 2.00 (s, 3H), 1.78-1.17 (m, 16H), 0.17 (s, 9H);
13C NMR (CDCI 3 , 100 M Hz): S 192.5, 161.7, 155.8, 102.7, 101.3, 99.0, 96.9, 90.4, 90.2,
89.1, 89.0, 87.5, 53.4, 34.0, 33.9, 30.8, 29.4, 28.7, 27.2, 26.9, 26.5, 24.3, 23.8, 23.7, 1.1.
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B. Com pounds 56-69

General synthesis for a-am ino phosphonates and a-am in o thiophosphonates: The
amine (1.0 eq) was w eighed into a 100 mL RB flask w ith 20 m L o f toluene and 0.5 g o f
3 A m olecular sieves then heated to dissolve the amine (if necessary). W hen the amine
was fully dissolved, the aldehyde (0.9 eq) was added via syringe while stirring and the
solution would turn cloudy. After 20 min, the reaction was clear and checked by 'H
NMR or LC MS for the formation o f the imine. Once reaction was complete, the toluene
was evaporated under reduced pressure and a thick oil was left behind. To the oil was
added toluene (2-5 mL) and a stir bar, and the flask was then cooled to 0° C with an ice
bath and purged with Ar(g). Either dimethyl phosphite (5-10 eq) or dimethyl
thiophosphite (0.85 eq) was added via syringe and the reaction was stirred at ambient
temperature for either 10 h for dimethyl thiophosphite or up to 4 d for dimethyl
phosphite. All reactions were monitored by unlocked 3IP N M R and TLC (DBQ stain).
When the reaction was complete, the solvent was removed under reduced pressure and
excess phosphite was rem oved with a K ugelrohr to afford a thick oil. All reactions were
purified with silica chromatography.
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0 ,0 -D im e th y l ester [2-M ethyI-l-(l-phenyl-ethylam ino)-propyI]-phosphonothionate
(56). [144]-a-M ethylbenzylam ine (1.88 g, 15.5 mmol) was dissolved in 10 mL o f

toluene followed by the addition o f isobutyryl aldehyde (1.01 g, 1.27 mL, 13.96 mmol)
and stirred at rt for 1 h. The reaction was concentrated to oil followed by the addition o f
2 mL toluene, dim ethyl thiophosphite (1.5 g, 11.87 mm ol), and stirred at rt for

8

h. After

concentrating to oil a silica colum n eluted with 5% EtOA c/hex afforded colorless oil 47
as a mixture o f diastereom ers (10:7), (2.42 g, 8.02 mmol,

6 8 %).

HRM S calcd for M +H+

ofC,4H24N 02PS 302.1343, found 302.1246.

'H N M R (CDCIs, 400 MHz): 5 7.39-7.21 (m, 5 H), 4.11-4.08 (m, 1H), 3.76 (d, J P0CH3 =
12.9 Hz, 1.5 H), 3.73 (d, J P0Cm = 12.9 Hz, 1.5 H), 3.70 (d, J POcm = 12.9 Hz, 1.5 H), 3.68
(d, JpocH3 = 1 2 .9 Hz, 1.5 H), 2.98 (dd, J PCH= 14.7, 2.6 Hz, 0.5 H), 2.71 (dd, J PCH = 11.0,
2.6 Hz 0.5 H), 2.36-2.25 (m, J = 2.6 Hz, 0.5 H), 2.17-2.06 (m, J = 2.6 Hz, 0.5 H) 1.77
(bs, 1H ), 1.34 (d, J = 6.4 Hz, 1.5 H), 1.30 (d, 6.4 Hz, 1.5 H), 1.10 (dd, J = 7.1, 2.0 Hz,
1.5 H), 0.98 (d, J = 7.1 Hz, 1.5 H), 0.93 (d, 7 = 7 .1 Hz, 1.5 H), 0.82 ( d d ,7 = 6 .4 , 1.3 Hz,
1.5 H);

13C NM R (CDC13, 100 MHz): 5 146.8,145.8, 129.5, 129.2,128.7, 128.2, 128.1, 63.2 (d,
J

p c h

= 94.6 Hz), 63.0 (d, J PCH = 106.8 Hz), 57.2, 54.5 (d, J P0Cm = 9.2 Hz), 54.1 (d,
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Jpocm — 9-2 Hz), 53.9 (d, Jpocm -

6.1

Hz), 53.1 (d, Jpocm - 9.2 Hz), 30.1 (d, J = 9

Hz), 30.0 (d, J = 9.1 Hz), 26.3, 24.1, 22.8 (d, J = 15.3 Hz), 22.4 (d, J = 15.3 Hz),
18.3,17.8.

31P N M R (CDC13, 171 MHz): 5 108.2, 104.9.
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0 ,0 -D im e th y l ester [2-M ethyI-l-(l-phenyl-ethylam ino)-propyl]-phosphonate (57).
[144]-a-M ethylbenzylam ine (1.88 g, 15.5 mmol) was dissolved in 10 m L o f toluene
followed by the addition o f isobutyryl aldehyde (1.01 g, 1.27 mL, 13.96 mm ol) and
stirred at rt for 1 h. The reaction was then concentrated and followed by the addition o f 2
mL toluene, dim ethyl phosphite (3.24 g, 29.46 mmol), and stirred at rt for 72 h. After
concentrating to oil a silica column eluted with 1% M eO H/CHCL afforded colorless oil
57 as a m ixture o f diastereomers (12:9), (2.23 g, 7.42 mmol, 48%). HRM S calcd for
M +H+ o f C 1 4 H 2 4 N O 3 P 286.1572, found 286.1549.

'H N M R

(C D C I3,

400 MHz):

8

7.26-7.21 (m 5 H), 4.10-4.07 (m, 1H), 3.71 (d, J P0CH3 =

10.4 Hz, 3 H), 3.70 (d, Jpocm = 10.4 Hz, 3 H), 2.60 (m, 1 H), 2.12-2.05 (m, 1 H), 1.36 (d,
7 = 6.4 Hz, 3 H ), 1.09 (d, 6.4 Hz, 3 H), 1.01 (d, 7 = 6 .4 Hz, 3 H);

13C N M R (C D C 1 3,

100 MHz): 5 146.4,145.5, 129.8, 129.2,128.9, 128.3, 128.1, 53.8 (d,

Jpocm = 9.2 Hz), 53.1 (d, Jpocm =

6.1

Hz), 53.0 (d, Jpocm =

6.1

Hz), 52.7 (d, Jpocm =

6.1 Hz), 51.5 (d, J pch = 138.8 Hz), 51.1 (d, J PCH = 120.8 Hz), 29.9 (d, 7 = 9.1 Hz), 29.6
(d, 7 = 9.1 Hz), 26.2, 24.2, 22.4 (d, 7 = 12.2 Hz), 21.9 (d, 7 = 12.2 Hz).
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31P N M R (CDCI 3 , 171 MHz): 5 33.0, 31.3.
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0 ,0 -D im e th y l ester [l-(2-H ydroxy-l-phenyI-ethylam ino)-2-m ethyI-propyI]phosphonothionate (58). [144]-Phenylglycinol (1.13 g, 18.3 mm ol) dissolved in 10 mL
o f toluene followed by the addition o f isobutyryl aldehyde (0.59 g, 8.20 mm ol) and
stirred at rt for 1 h. The reaction was then concentrated, followed by the addition o f 2 mL
o f toluene, dim ethyl thiophosphite (0.93 g, 7.38 mm ol), and stirred at rt for

8

h. The

reaction was then concentrated to oil followed by a silica column eluted w ith 1 %
M eO H /CH Cb to afford colorless oil 58 as a m ixture o f diastereomers (11:8), (2.23 g,
7.42 mmol, 48%). HRMS calcd for M +H+ o f C 14H24N03PS 318.1292, found 318.1201.

'H NM R (CDC13, 400 MHz):

8

7.33-7.23 (m 5 H), 4.14-3.98 (m, 1H), 3.72 (d, Jpocm =

12.9 Hz, 1.5 H), 3.71 (d, J POcm = 12.9 Hz, 1.5 H), 3.69-3.66 (m, 7 = 3.9 Hz, 2 H) 3.623.55 ( m ,7 = 3.9 Hz, 1 H) 3.59 (d, J POCm = 12.9 Hz, 1.5 H), 3.55 (d, J P0Cm = 12.9 Hz,
1 .5

H), 2.95 (dd, JPCH = 16.2, 2.6 Hz, 0.5 H), 2.81 (dd, J PCH = 9.7, 2.6 Hz, 0.5 H), 2.33-

2.14 (m, 7 = 7.2 Hz, 1 H), 1.09 (d, 7 = 6.4 Hz, 1.5 H), 1.01 (d, 6.4 Hz, 1.5 H), 0.92 ( d ,7 =
6.4 Hz, 1.5 H), 0.85 (d, 7 = 6.4 Hz, 1.5 H);

I3 C N M R (C D C 13, 100 MHz): 5 141.6, 141.4, 129.4, 129.3, 129.1, 129.0, 128.7,
6 8 .2

6 8 .8 ,

, 64.9, 64.5, 55.9 (d, JPCH = 134.3 Hz), 57.7 (d, J PCH = 152.6 Hz), 54.0 (d, J P0Cm =

6.1 Hz), 53.9 (d,

J P o c h

3

= 9.2 Hz), 53.2 (d,

J P o c h

3

= 6.1 Hz), 53.1 (d,

J P o c h
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3

= 9.2 Hz),

30.4 (d, J = 6.1 H z), 29.5 (d, J = 6.1 Hz), 21.8 (d, J = 12.2 Hz), 21.2 (d, J = 12.2 Hz),
19.6, 18.5.

31P NM R (CDC13, 171 MHz): 5 106.3, 103.6.
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O,O-Dim ethyl ester [3-M ethyl-l-(l-phenyl-ethylam ino)-butyl]-phosphonothionate
(59). [144]-a-M ethylbenzylam ine (1.13 g, 9.3 mmol) dissolved in 10 mL o f toluene
followed by the addition o f 3-methyl-butyraldehyde (0.81 g, 9.3 mmol) and stirred at rt
for 1 h. The reaction was then concentrated, followed by the addition o f 2 mL o f toluene,
dimethyl thiophosphite (1.06 g, 8.37 mmol), and stirred at rt for 10 h. After
concentrating to oil a silica column eulated w ith 0.5% EtOAc/hex afforded colorless oil
59 with partial separation o f diastereomers (10:8), (2.19 g, 6.94 mmol, 75%). HRMS
calcd for M +H + o f C i 5H 26N 0 2PS 316.1500, found 316.1555.

M ajor isomer:
‘H NM R (CDC13, 400 MHz): 5 7.35-7.18 (m 5 H), 4.07 (dq, 7 = 6.4, 1.9 Hz, 1H), 3.74
(d, Jpocm = 12.9 Hz, 3 H), 3.68 (d, J P0Cm = 12.9 Hz, 3 H), 3.02 (dt, J PCH = 8.4, 5.2 Hz,

1

H), 1.92-1.86 (m, 7 = 6.4 Hz, 1 H), 1.66-1.54 (m, 7 = 5.2 Hz, 1 H), 1.42 (d, 7 = 8 .4 Hz, 2
H), 1.31 (d, 6.4 Hz, 3 H), 0.89 (d, 7 = 6.4 Hz, 3 H), 0.84 (d, 7 = 6.4 Hz, 3 H);

13C N M R (C D C 13,

100 M Hz): 5 145.9, 129.3, 128.5, 128.2, 57.0, 56.3 (d ,7 PC//= 103.8

Hz), 54.8 (d, 7 PocH3 =

6

.1 Hz), 53.7 (d, J Poch 3 ~ 9.2 Hz), 41.3 (d, 7 = 9.2 Hz), 26.0, 24.8,

24.6,22.0.
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3IP NMR (CDCI3 , 171 MHz): 5 109.4.

M inor isomer:
‘H NMR (CDCI 3 , 400 M Hz): 5 7.35-7.21 (m 5 H), 4.07 (dq, J = 6.4, 1.9 Hz, 1H), 3.75
(d, J Pocm = 12.9 Hz, 3 H), 3.02 (dt, J PCH = 8.4, 5.2 Hz, 1 H), 1.92-1.86 (m, J = 6.4 Hz, 1
H), 1.64-1.56 (m, J = 5.2 Hz, 1 H), 1.41 (d, J = 8.4 Hz, 2 H), 1.31 (d, 6.4 Hz, 3 H), 0.88
(d, J = 6.4 Hz, 3 H), 0.83 (d, J = 6.4 Hz, 3 H);

l3C NMR (CDCI 3 , 400 M Hz): 5 146.6, 129.4, 128.1, 128.0, 56.9, 56.5 (d, J PCH = 116.0
Hz), 54.8 (d, J Pocm = 9.2 Hz), 53.8 (d, J P0Cm = 6.1 Hz), 41.3 (d, J = 9.1 Hz), 25.9, 24.8,
24.2,23.1.

31P N M R (C D C 13,

400 M Hz):

6

106.1.
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0 ,0 -D im e th y l ester [3-M ethyl-l-(l-phenyl-ethylam ino)-butyI]-phosphonate (60).
[144]-a-M ethylbenzylam ine (1.88 g, 15.5 mmol) dissolved in 10 m L o f toluene followed
by the addition o f 3-m ethyl-butyraldehyde (1.30 g, 15.45 mm ol) and stirred at rt for 1 h.
The reaction was then concentrated followed by the addition o f 2 m L o f toluene,
dimethyl phosphite (3.41 g, 31.02 mmol) and stirred at rt for 96 h. A fter concentrating to
oil a silica colum n eluted w ith 70% C H C ^/hex afforded colorless oil 60 as a mixture o f
diastereomers (10:4), (2.93 g, 9.81 mmol, 63%). HRM S calcd for M +H + o f C ^ N C ^ P
300.1728, found 300.1697.

'H N M R (CDCI 3 , 400 MHz): 5 7.27-7.14 (m 5 H), 4.10 (dq, J = 6.4, 3.2 Hz, 1 H), 3.71
(d, Jpocm = 10.4 Hz, 3 H), 3.70 (d, J POCm = 10.4 Hz, 3 H), 2.65-2.59 (m, J PCh =%A, 3.2
Hz, 1 H), 1.77-1.67 (m, 7 = 6 .4 Hz, 1 H ), 1.62-1.52 (m, J = 6.4 Hz, 2 H), 1.31 (d, 6.4 Hz,
3 H), 0.76 (d, J = 7.1 Hz, 3 H), 0.35 (d, J = 7.1 Hz, 3 H);

13C N M R (C D C 13,

100 M Hz): 5 146.2, 145.8, 129.4, 129.3, 128.3, 128.2, 128.1, 128.0,

57.2, 56.7 (d, Jpocm ~ 9.2 Hz), 54.1 (d, Jpocm =

6.1

Hz), 53.7 (d, Jpocm =

6.1

Hz), 53.5

(d, Jpocm = 6.1 Hz), 50.8 (d, JPCH = 152.6 Hz), 50.6 (d, J PCH = 146.5 Hz), 41.2, 40.8,
25.9, 25.6, 25.2, 24.8, 24.6, 23.9, 21.8.
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31P NM R (CDCI 3 , 171 MHz):

8

33.1, 32.0.
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0 ,0 -D im e th y l ester [l-(2-H ydroxy-l-phenyl-ethylam ino)-3-m ethyl-butyI]phosphonothionate (61). [144]-Phenylglycinol (1.20 g, 8.73 m m ol) dissolved in 10 mL
o f toluene followed by the addition o f 3-methyl-butyraldehyde (0.745 g, 8.69 mmol) and
stirred at rt for 1 h. The reaction was then concentrated followed by the addition o f 2 mL
o f toluene, dim ethyl thiophosphite (0.99 g, 7.87 mmol) and stirred at rt for
concentrating to oil a silica column eluted with

C H C I3

8

h. After

afforded colorless oil 61 as a

mixture o f diastereom ers (2.08 g, 6.61 mmol, 76%). HRM S calcd for M +H + o f
Q 5H 26N O 3PS 331.1371, found 331.1333.

'H N M R

(C D C I3,

400 MHz):

6

7.33-7.23 (m 5 H), 4.16-4.12 (m, 1H), 4.02 (dd, J = 7.1,

2.6 Hz 2 H), 3.76 (d, J POcm = 12.9 Hz, 1.5 H), 3.73 (d,
Jpocm = 12.9 Hz, 1.5 H), 3.64 (d

, J

P O C h s

J P O c h

3

= 12.9 Hz, 1.5 H), 3.66 (d,

= 12.9 Hz, 1.5 H), 3.04-2.97 (m,

J

P C H =

8.4,

2.6

Hz, 1 H), 1.88-1.74 (m, .7=7.1 Hz, 1 H), 1.62-1.34 (m, J = 7.1 Hz, 2 H), 0.86 (d, 7 = 7.1
Hz, 1.5 H), 0.83 (d, 7.1 Hz, 1.5 H), 0.81 (d, J = 6 A Hz, 1.5 H), 0.48 (d, .7 = 6 .4 Hz, 1.5
H);

13C N M R (C D C 13,

100 MHz): 5 141.5, 141.3, 129.6, 129.0, 128.9, 128.8, 128.7,68.5,

67.8, 64.2, 63.4 (d, Jpocm ~ 9.2 Hz), 56.9 (d,

J p c h

~ 119.0 Hz), 56.7 (d,

J

P c h
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=

1 12.9

Hz), 54.7 (d, Jpocm = 9.2 Hz), 54.4 (d, J P0Cm = 6.1 Hz), 53.9 (d, J P0Cm = 9.2 Hz), 41.2
(d, J =

6

.1 Hz), 41.0 (d, / = 6 .1 Hz), 26.2, 26.0, 24.9, 24.8, 24.1, 23.1.

3IP NM R (CDCI 3 , 171 MHz): 5 107.3, 105.3.
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0 ,0 -D im e th y l ester [l-(2-H ydroxy-l-phenyl-ethylam ino)-3-m ethyl-butyl]phosphonate (62). [144]-Phenylglycinol (1.74 g, 12.7 mmol) dissolved in 10 m L o f
toluene was put into a 50 mL RB, followed by the addition o f 3-m ethyl-butyraldehyde
(0.98 g, 11.43 m m ol) and stirred at rt for 1 h. The reaction was then concentrated
followed by the addition o f 4 mL o f toluene, dim ethyl phosphite (2.52 g, 22.86 mmol),
and stirred at rt for 72 h. After concentrating to oil a silica colum n eluted w ith 1%
M eOH/CHCL afforded colorless oil 62 as a mixture o f diastereom ers (4:1), (1.65 g, 5.24
mmol, 46%). H RM S calcd for M +H+ o f C i 5H 26N 0 4P 315.1599, found 315.1632.

‘H N M R (CDC13, 400 MHz): § 7.34-7.23 (m 5 H), 4.11-4.00 (m, 1H), 4.02 (dd, 7 = 7.1,
2.6 Hz 2 H), 3.81 (d, J P0Cm = 10.4 Hz, 1.5 H), 3.75 (d, J P0Cm = 10.4 Hz, 1.5 H), 3.71 (d,
Jpocm = 10.4 Hz, 1.5 H), 3.70 (m, 2 H), 3.66 (d, J POcm = 10.4 Hz, 1.5 H), 2.93-2.84 (m,
J pch = 8 A B z , 1 H), 1.83-1.71 (m, 7 = 6 .4 Hz, 1 H), 1.64-1.45 (m, 7 = 6.4 Hz, 2 H), 0.86
(d, 7 = 6.4 Hz, 1.5 H), 0.84 (d, 6.4 Hz, 1.5 H), 0.78 ( d ,7 = 6 .4 Hz, 1.5 H), 0.55 ( d ,7 = 6 .4
Hz, 1.5 H);

13C NM R (CDCI 3 , 100 MHz): 5 141.8, 141.5, 129.6, 129.4, 129.3, 128.8, 128.7, 68.5,
67.8, 65.2, 63.5, 63.4, 54.5 (d, Jpocm ~

6.1

Hz), 54.2 (d, Jpocm =

6.1

Hz), 53.6 (d, Jpocm
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= 6.1 Hz), 53.5 (d, Jpocm = 9.2 Hz), 51.9, (d, J PCh = 149.5 Hz), 50.9 (d, J PCH = 152.6
Hz), 41.4, 40.8, 26.0, 24.7, 23.8, 23.4, 21.9.

31P NM R (CDCI 3 , 171 MHz): 5 32.7, 32.0.
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0 ,0 -D im e th y l ester [l-(2-H ydroxy-l-phenyl-propylam ino)-3-phenyI-m ethyl]phosphonate (63). L-threonine methyl ester (1.039 g, 7.8 mm ol) dissolved in 10 mL o f
CH 2CI2 was put into a 50 m L RB, followed by the addition o f benzaldehyde (0.79 mL,
0.828 g, 7.8 m m ol), K 2 CO 3 (1.62 g, 11.7 mmol), and stirred at rt for 3 h. The reaction
was then concentrated followed by the addition o f 2 ml o f toluene, dimethyl
thiophosphite (0.84 g,

6.66

mmol), and stirred at rt for 10 h. A fter concentrating to oil a

silica column eluted with 70% CH^Chihex afforded colorless oil 63 as a m ixture o f
diastereomers (8:3), (1.65 g, 5.24 mmol, 46%). HRM S calcd for M +H+ o f C i 4H 23N 0 5PS
348.1034, found 348.1046.

M ajor isomer:
'H NM R (CDCI 3 , 400 MHz): 5 7.40-7.20 (m, 5H), 4.07 (d, 1 H, J PCH = 14.8 Hz), 3.863.79 (m, 1H), 3.75 (d, 3 H,
Hz), 2.95 (d, 1 H,

J

13C N M R (C D C 13,

—

J

p o

c h

s

= 13.6 Hz), 3.37 (s, 3 H), 3.33 (d, 3 H, J P0Cm =12.8

6.4 Hz), 1.15 (d, 3 H, 7 = 6.4 Hz);

100 M Hz): 5 173.20, 134.9, 133.8, 129.2, 128.7, 128.6, 128.4,68.2,

66.7, 65.9 (d, J CP = 127.50 Hz), 54.2 (d, J P 0C H 3 = 9.1 Hz), 53.7 (d,

J

p o

c h

s

= 6.1 Hz) 51.8,

19.1.
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3!P NMR (CDCI3 , 171 MHz): 5 97.2.

M inor isomer:
'H N M R (CDCI 3 , 400 MHz): 5 7.40-7.20 (m, 5H), 4.11 (d, J PCH = 14 Hz, 1 H), 3.75-3.70
(m, 1 H), 3.67 (s, 3 H), 3.64 (d, J PCH3 = 13.6 Hz, 3 H), 3.52 (d, J POCm = 13.6 Hz, 3 H),
2.99 (d, 1 H, 7 = 6 .4 Hz) 1.13 (d, J - 6.4 Hz, 3 H);

13C N M R (C D C 13,

66.6,64.5

100 MHz):

6

173.0, 134.9, 133.8, 129.2, 129.1, 128.7, 128.4,67.9,

(d, J CP = 118.4 Hz), 54.3 (d, J POc w = 6.1 Hz), 53.6 (d, JP0Cm =

6.1

19.3.

31P N M R

(C D C I3,

171 MHz):

6

96.8.
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Hz) 51.9,

0 ,0 -D im e th y l ester [l-(l-PhenyI-ethylam ino)-butyI]-phosphonothionate (64). [144]a-M ethylbenzylam ine (1.88 g, 15.51 mmol) dissolved in 10 mL o f toluene was put into a
50 m L RB, followed by the addition o f rc-butyraldehyde (1.062 g, 14.73 mmol) and
stirred at rt for 1 h. The reaction was then concentrated followed by the addition o f
dimethyl thiophosphite (1.67 g, 13.26 mmol), and stirred at rt for

8

h. A fter

concentrating to oil a silica column eluted with 1% EtOAc/hex afforded colorless oil 64
as partial seperation o f diastereomers (9:19), (3.38 g, 11.21 mm ol, 85%).

HRMS

calcd

for M +H+ o f C 14 H 2 4 N O 2 P S 302.1343, found 302.1301.

M ajor isomer:
'H N M R (CDCI 3 , 400 MHz): 5 7.35-7.21 (m, 5 H), 4.03 (q, J = 6.4, 1 H), 3.74 (d, J P0CH3
= 12.9 Hz, 3 H), 3.67 (d, JPOcm = 12.9 Hz, 3 H), 2.92 (dt, J PCh = 8.4, 2.6 Hz,

1

H), 1.84-

1.37 (m, J = 7.1 Hz, 5 H), 1.32 (d, J = 6.4 Hz, 3 H), 0.90 ( t , J = 7.1 Hz, 3 H);

13C N M R (C D C 13, 1 0 0

MHz):

8

146.2, 129.5, 128.2, 128.0, 58.0 (d, J PCh = 116.0 Hz),

56.6, 54.8 (d, J POcm = 6.1 Hz), 54.1 (d, J P0Cm = 6.1 Hz), 33.4 (d, 7 = 6.1 Hz), 25.0, 20.5,
15.2.
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31P N M R (CDCI 3 , 171 MHz): 5 105.0.

M inor isomer:
'H N M R (CDCI 3 , 400 MHz):

8

7.30-7.20 (m, 5 H), 4.10 (q, 7 = 6.4, 1 H), 3.77 (d, JP0Cm

= 12.9 Hz, 3 H), 3.72 (d, J P0Cm = 12.9 Hz, 3 H), 2.77 (dt, JPCH = 8.4, 3.2 Hz, 1 H), 1.63
(bs, 1 H), 1.58-1.49 (m, 7 = 7 .1 Hz, 4 H), 1.31 (d, 7 = 6.4 Hz, 3 H), 0.71 (t, 7 = 7 .1 Hz, 3
H);

13C N M R (C D C 13,

100 M Hz): 5 146.0, 129.3, 128.4, 128.1, 57.8 (d, J PCH = 131.2 Hz),

57.4, 54.7 (d, J POcm = 9.2 Hz), 53.8 (d, J P0Cm = 9.2 Hz), 34.3 (d, 7 =

6.1

Hz), 26.1,

14.8.

3 IP N M R (C D C 1 3,

171 MHz): 5 108.6.
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2 0 .1 ,

0 ,0 -D im e th y l ester [l-(l-P henyl-ethylam ino)-butyl]-phosphonate (65). [144]-aM ethylbenzylam ine (1.88 g, 15.51 mmol) dissolved in 10 mL o f toluene was put into a
50 mL RB, followed by the addition o f n-butyraldehyde (1.062 g, 14.73 mm ol) and
stirred at rt for 1 h. The reaction was then concentrated followed b y the addition o f 2 mL
o f toluene, dim ethyl phosphite (3.24 g, 29.45 mmol), and stirred for 96 h. After a
concentrating to oil a silica column eluted with 1% M eOH/CHCI 3 afforded colorless oil
65 as a m ixture o f diastereomers (9:10), (3.30 g, 11.56 mmol, 75%). HRM S calcd for
M +H + o f C i 4 H 24N 0 3P 286.1572, found 286.1602.

‘H N M R (CDCI 3 , 400 MHz): 5 7.28-7.15 (m 5 H), 4.08 (dq, 7 = 6.4, 2.6 Hz, 1 H), 3.71
(d, Jpoch 3 = 10.4 Hz, 3 H), 3.70 (d, Jpocm = 10.4 Hz, 3 H), 2.62 (dt,

J

p c

h

~ 9.1, 3.8 Hz, 1

H), 1.58-1.32 (m, 7 = 7.1 Hz, 4 H), 1.26 (d, 7 = 6.4 Hz, 3 H), 0.67 (t, 7 = 7 .1 Hz, 3 H);

!3C N M R (CDCI 3 , 100 MHz):

8

145.9, 129.4, 128.2, 128.1, 57.4, 53.7 (d, J P0CH3 = 9.2

Hz), 53.6 (d, Jpocm = 6.1 Hz), 52.3 (d, J PCH = 143.4), 34.0 (d, 7 =

6.1

Hz), 25.7,

14.7.

3IP N M R

(C D C I3,

171 MHz): 5 37.2, 31.6.
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2 0 .1 ,

0 ,0 -D im e th y l ester [l-(2-H ydroxy-l-phenyl-ethylam ino)-butyl]-phosphonothionate
( 6 6 ). [144]-Phenylglycinol (3.52 g, 25.69 mm ol) dissolved in 10 mL o f toluene was put
into a 50 mL RB, followed by the addition o f ft-butyraldehyde (1.80 g, 24.9 mmol) and
stirred at rt for 1 h. The reaction was then concentrated followed by the addition o f 2 mL
toluene, dim ethyl thiophosphite (2.92 g, 23.12 m m ol), and stirred at rt for 7 h. After
concentrating to oil a silica column eluted with 5% EtOAc/hex afforded colorless oil 66
as a mixture o f diastereomers (10:6), (3.38 g, 24.9 mmol, 85%). HRM S calcd for M +H+
o f C 14H 24N O 3PS 318.1292, found 318.1331.

*H NM R

(C D C I3,

400 MHz): S 7.34-7.26 (m 5 H), 4.03-4.00 (m, 7 = 7.1 Hz, 1 H), 3.78-

3.70 (m, J = 7.1 Hz, 2 H), 3.68 (d, JPOcm = 12.9 Hz, 1.5 H), 3.66 (d, J P0Cm = 12.9 Hz, 3
H), 3.60 (d, JpocH3 ~ 12.9 Hz, 1.5 H), 3.58 (d, J Poch 3 = 12.9 Hz, 1.5 H), 2.95 (m, J Pch ~
7 .7 U z, 1 H), 1.84-1.71 (m, 7 = 7 .1 Hz, 2 H), 1.65-1.37 (m, 7 = 7.1 Hz, 2 H), 0.87 ( t , J =
7.1 Hz, 3 H), 0.74 (t, 7 = 7.1 Hz, 3 H);

l3C NM R (CDCI 3 , 100 MHz):

6

141.4, 141.3, 129.6, 129.5, 128.9, 128.8, 128.7,

6 8 .6

,

67.9, 64.4, 63.3, 58.4 (d, J Pch = 109.9 Hz), 58.2 (d, J Pch = 119.0 Hz), 54.8 (d, J Pocm =
9.2 Hz), 54.6 (d, J Pocm ~ 6.1 Hz), 54.3 (d, JPoch 3 = 6.1 Hz), 53.9 (d, J Pocm = 9.2 Hz),
34.2 (d, 7 = 6.1 Hz), 33.2 ( d ,7 = 6 .1 Hz), 20.6, 2 0 .5 ,2 0 .2 ,2 0 .1 , 15.2, 14.8.
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31P N M R ( C D C I 3 , 1 7 1 M H z ) :

8

1 0 6 .5 , 1 0 4 .3 .
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MeO

M eO^J/S
P

3R S, 1R -

.OH
r

0 ,0 -D im e th y l ester [(2-H ydroxy-l-phenyl-ethylam ino)-phenyl-m ethyl]-

phosphonothionate (67). [144]-Phenylglycinol (0.51 g, 3.72 mm ol) dissolved in 10 mL
o f toluene was put into a 50 m L RB, followed by the addition o f benzaldehyde (0.40 g,
3.74 mmol) and stirred at rt for 1 h. The reaction was then concentrated followed by the
addition o f 3 mL o f toluene, dimethyl thiophosphite (0.46 g, 3.79 m m ol), and stirred at rt
for 7 h. A fter concentration to oil a silica colum n eluted w ith 50% hex/Et 2 0 afforded
colorless oil 67 as a mixture o f diastereomers (0.99 g, 2.77m m ol, 56%). Anal. Calcd for
C 17H 22N O 3PS: C, 58.11; H, 6.31; N, 3.99. Found: C, 57.90; H, 6.42; N, 3.89.

M ajor isomer:
'H N M R (CDCI 3 , 400 MHz): 5 7.33-7.21 (m, 10 H), 4.20 (d, JPCH = 17.2 Hz, 1H), 4.013.95 (m, 1 H), 3.78 (d, JP0CH3 = 15.6 Hz, 3 H), 3.79-3.73 (m, 1H), 3.32 (d,

J

P O c h

3

=12.8

Hz, 3 H), 2.64 (br s, 1 H);

13C N M R (C D C 13, 1 0 0

MHz):

6

140.0, 135.7, 128.5, 128.4, 128.3, 128.1, 127.7, 127.4,

66.0, 62.9 (d, J PC = 116.0 Hz), 62.5, 62.4, 54.5 (d, JP0CH3 = 6 .1 Hz), 53.8 (d, J POCH3 = 9.1
Hz);

31

P N M R (CDCL, 171 MHz):

6

100.5.
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M inor isomer:
!H NM R ( C D C I 3 , 400 M Hz): 5 7.36-7.21 (m , 10H), 3.97 (d , J PCH = 18.8 Hz, 1 H), 3.74
(d , Jpocm = 12.8 Hz, 3 H) 3.68-3.58 (m, 3H), 3.45 (d , J POcm = 12.8 Hz, 3 H), 2.28 (b r s,

1H);

13C N M R (C D C 13,

127.6,

100 MHz): 5 138.7, 134.4, 129.0, 128.9, 128.7, 128.4, 128.3, 127.9,

67.0, 62.3 (d , J p c ~

122.0

Hz), 61.5, 61.3, 54.1 (d , Jpocm =

6.1

Hz) 53.3 (d , Jpocm

= 6.1 Hz);

31P NM R (CDCI 3 , 171 MHz): 5 98.1.
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MeO

MeO^

I/S

P

0 ,0 -D im e th y l ester [[144]-Phenyl-(l-phenyl-ethylam ino)-m ethyl]phosphonothionate (68). [ 144]-Phenylglycinol (0.75 g, 6.2 mm ol) dissolved in 10 mL
o f toluene was put into a 50 mL RB, followed by the addition o f benzaldehyde (0.66 g,
6.2

mmol), and stirred at rt for 1 h. The reaction was then concentrated followed by the

addition o f 2 m L o f toluene, dimethyl thiophosphite (0.78 g, 6.2 mmol), and stirred at rt
for

8

h. A fter concentrating to oil a silica column eluted w ith 2% Et 2 0 /hex to yield

colorless oil 68 as a mixture o f diastereomers (8:2), (1.32 g, 3.95 mmol, 64%). HRMS
calcd for M +H + o f C 17H 22N O 2PS calcd for 336.1187, found 336.1194.

'hi N M R (CDCI 3 , 400 MHz): 5 7.37-7.21 (m, 10 H), 4.24 (d, Jpch = 1 9 .2 Hz, 1 H), 3.93
(q, J = 6.4 Hz, 1 H), 3.84 (d, JP0Cm = 12.8 Hz, 3 H), 3.36 (d, JP0Cm = 12.8 Hz, 3 H), 2.45
(br s, 1H), 1.36 (d, / = 6.4 Hz, 3 H);

13C N M R (C D C 13,

100 MHz): 5 145.0, 135.9, 128.4, 128.4, 128.3, 128.1, 127.0, 126.7,

62.6 (d, J Cp = 115.3 Hz), 55.2 (d, J P0Cm = 9.1 Hz), 54.1 (d, JPOcm = 6.1 Hz), 53.7, 23.0;

3 IP N M R (C D C 1 3,

171 MHz): 5101.6.
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0 ,0 -D im e th y l ester 2-{[(Dim ethoxy-thiophosphoryl)-phenyl-m ethyl]am ino}-3hydroxy-propionate (69). To a suspension o f L-serine m ethyl ester hydrochloride (0.54
g, 3.47 mm ol) in THF (15 mL) was added TEA (0.48 mL, 0.35 g, 3.44 mmol). The
reaction was stirred at 0 °C for 30 min and filtered rapidly under vacuum. The solvent
was evaporated to dryness to give L-serine methyl ester as an off-yellow oil (0.34 g, 2.82
mmol). To a solution o f L-serine, methyl ester in CH 2 CI2 (5 mL) was added
benzaldehyde (0.27 mL, 0.28 g, 2.66 mmol) and m olecular sieves (3 A, 0.5 g). The
reaction m ixture was stirred at rt for 2 h and filtered through Celite. Dimethyl
thiophosphite 5 (0.24 mL, 0.36 g, 2.85 mmol) was added and the reaction mixture was
stirred at 0 °C for 12 h. The solvent was evaporated to dryness to give crude product
(0.688 g) as yellowish oil that was purified by column chrom atography (30% hex/Et 2 0 )
to yield 69 as partially separated diastereomers. Anal. Calcd for iCnL^oNOsPS: C, 46.84;
H, 6.05; N, 4.20; Found: C, 46.49; H, 5.96; N, 4.21.

M ajor isomer:
'H N M R (CDCI 3 , 400 MHz): 5 7.39-7.26 (m, 5H), 4.16 (d,

J

C p h

= 20.4 Hz, 1 H), 3.81-

3.55 (m, 2H), 3.75 (d, J P0Cm = 13.2 Hz, 3 H), 3.60 (s, 3H), 3.45-3.32 (m, 1H), 3.38 (d,
Jpocm = 13.6 Hz, 3 H), 2.91 (br s, 1 H);
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13C N M R (C D C 13,

100 MH z): 5 172.4, 134.7, 128.5, 128.5, 128.3, 63.7 (d, J PC = 128.1

Hz), 61.6, 60.2, 54.3 (d, J POCm = 9.1 Hz), 53.7 (d, J POCH3 = 6.1 Hz), 52.2;

31P N M R (CDCI 3 , 171 MHz):

8

97.8.

M inor isomer:
'H NM R (CDCI 3 , 400 MHz) : 8 7.42-7.26 (m, 5H), 4.29 (d, J Pch = 15.6 Hz, 1 H), 3.743.64 (m, 2 H), 3.69 (d, J P0Cm =13.2 Hz, 3 H), 3.70 (s, 3H), 3.53 (d, J POcm = 13.2 Hz, 3
H), 3.35-3.30 (m, 1H);

13C N M R (C D C 13,

100 MH z): 5 172.6, 134.2, 129.1, 129.1, 128.4, 128.3, 64.2 (d, J PC =

119.1 Hz), 6 3 .1,60.0, 54.3 (d, J POCH3 = 6.1 Hz), 53.7 (d, J P0CH3 = 6.1 Hz), 52.1;

31P N M R (CDC13, 171 MHz):

8

97.2.
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D. Com pounds 70-72

General synthesis for a-am ino phosphonic and a-am inothiophosphonic acids:
a-A m inophosphonate or a-am inothiophosphonate (0.7-1.7 mm ol) was placed into a 50
mL RJB flask w ith 10 mL o f acetone and a w ater condenser. To this solution was added
potassium ethyl xanthate (0.9 eq) and then the reaction was refluxed for 8-20 h while
m onitoring by reaction w ith unlocked 3!P N M R until the reaction was complete. The
work up for each reaction was specific for the com pound and is listed with the spectral
data.
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[2-M ethyl-l-(l-phenyl-ethyIam ino)-propyl]-phosphonothioic acid O -m ethyl ester
(70). Compound 56 (0.44 g, 1.48 mmol) was reacted w ith PEX (0.23 mg, 1.4 mmol) at
reflux for

8

h and then concentrated under reduced pressure to afford light yellow oil.

The oil was dissolved in Et 2 0 and a white pow der crashed out o f solution. The
1

precipitate was isolated and then analyzed by H,

13

C, and

31

P N M R showing a mixture o f

4 diasteromers (10:8:7:5), (0.086 g, 0.30 mmol, 21%). HRMS calcd for M +H + o f
C 13H 22N O 2 PS 288.1187, found 288.1225.

‘H N M R (CDCI 3 , 400 MHz): 5 7.70-7.35 (m, 5H), 4.68 (q, J = 6.4 Hz, 0.5 H), 4.38 (q, 7
= 6.4 Hz, 0.5 H), 3.72 (d, 7 = 12.9 Hz, 0.75 H), 3.70 (d, 7 = 12.9 Hz, 0.75 H), 3.47 (d, 7 =
12.9 Hz, 0.75 H), 3.34 (d, 7 = 12.9 Hz, 0.75 H), 2.85-2.74 (m, 1 H), 2.53-2.38 (m, J = 7.1
Hz, 1 H), 1.97-1.90 (m, .7= 7.1 Hz, 3 H), 1.88 (d, 7 = 7.1 Hz, 0.75 H), 1.29 (d, 7 = 7 .1 Hz,
0.75 H), 1.27 (d, 7 = 7 .1 Hz, 0.75 H), 1.17 (d, 7 = 7 .1 Hz, 0.75 H), 1.09 ( d ,7 = 7 .1 Hz,
0.75 H), 1.06 (d, 7 = 7.1 Hz, 0.75 H), 0.81 (d, 7 = 7.1 Hz, 0.75 H), 0.76 ( d ,7 = 7 .1 Hz,
0.75 H).

I3C N M R (C D C 13, 100 MHz): 5 137.6, 137.3, 137.0, 136.6, 130.7, 130.6, 130.5, 130.3,
130.2, 129.9, 129.8, 129.0, 128.9,

6 6 .2

, 65.3, 65.1, 64.3, 62.5 (d, J PCH= 103.8 Hz), 62.4
162

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(d,

J p c h

~ 119.0 Hz), 61.5 (d,

= 6.1 Hz), 53.1 (d,

J p o c h

3

J p c h

~ 109.9 Hz), 61.1 (d,

J p c h

~ 128.2 Hz), 53.3 (d,

J p o c h s

— 6.1 Hz), 52.8 (d, Jpocm - 6.1 Hz), 51.9 (d, Jpocm — 6.1 Hz),

30.0, 29.4, 28.1, 23.7, 23.5, 23.0, 22.2, 21.5, 21.4, 21.1, 21.0, 18.7, 18.5.

31P NM R (CDC13, 171 MHz): 5 74.6, 72.3, 71.6, 68.2
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[l-(l-PhenyI-ethyIam ino)-butyl]-phosphonic acid m onom ethyl ester (71). Compound
65 (0.48 g, 1.69 mm ol) and PEX (0.26 g, 1. 6 mmol). W ere brought to reflux for 12 h and
then concentrated under reduced pressure to afford light yellow oil. The oil was
dissolved in Et 2 0 and a w hite powder crashed out o f solution. The precipitate was
isolated and then analyzed by 'H ,

13C,

and 31P N M R showing a m ixture o f 2 diasteromers

(0.057 g, 0.02 mm ol, 13%). HRMS calcd for M +H + o f C , 3H 22N 0 3P 272.1415, found
272.1456.

'H NM R (CDCI 3 , 400 M Hz):

8

7.58-7.34 (m, 5H), 4.69 (q, J = 6.4 Hz, 0.6 H), 4.32 (q, J

= 6.4 Hz, 0.4 H), 3.60 (d, J = 11.0 Hz, 2.1 H), 3.41 (d, J = 11.9 Hz, 0.9 H), 2.76-2.51 (m,
1 H), 2.09-1.11 (m, 7 = 7 .1 Hz, 4 H), 1.82-1.79 ( m , J = 6.4 Hz, 3 H), 0.83 (t, .7=7.1 Hz,
0.9 H), 0.64 (t, 7 = 7 .1 Hz, 2.1 H).

13C N M R (C D C 13,

100 M Hz): 5 138.3, 138.2, 130.3, 130.2, 130.0, 129.0, 128.8, 61.2,

59.7, 57.8 (d, J P0Cm = 9.2 Hz), 55.3 (d, J PCH = 149.5 Hz), 53.9 (d, J PCH = 147.3 Hz), 52.9
(d, Jpocm = 6.1 Hz), 32.0, 29.9, 22.2 (d, J = 9.2 Hz), 20.8 (d, J = 9.2 Hz), 15.2, 14.3.

3 IP N M R (C D C 1 3,

171 M Hz): 5 14.8, 14.6.
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[3-M ethyl-l-(l-phenyl-ethylam ino)-butyl]-phosphonothioic acid O -m ethyl ester (72).
Compound 59 (0.25 g, 0.78 mmol) and PEX (0.12 g, 0.74 mmol) w ere refluxed for 10 h
and then transferred to a separatory funnel. Then 50 m L o f 0.2 M NaO H was added to
the funnel followed by an extraction with CHCI 3 (3 x 40 mL). A fter the CHCI 3
extraction, solid citric acid was added until the pH was about 5 and then CH Chhsopropyl
alcohol (4:1) was used to extract the product from the w ater layer. All organic layers
from the C H C hiisopropyl alcohol extractions were com bined and dried over N a 2 S 0 4
followed by concentration by reduced pressure to afford a light tan foam. The foam was
1 1 3

isolated and then analyzed by H,

C, and

(3:2), (0.041 g, 0.01 mm ol, 18%).

HRMS

31

P

NM R

calcd for

showing a m ixture o f 2 diasteromers
M +H +

o f C 1 4 H 2 4 N O 2 P S 302.1343,

found 302.1389.

'H NM R (CDCI 3 , 400 M Hz): 5 7.57-7.32 (m, 5H), 4.71-4.51 (m, .7 = 7 .1 Hz, 1 H), 3.72
(d, .7= 12.9 Hz, 1.2 H), 3.62 (d, 7 = 12.9 Hz, 1.8 H), 2.93-2.81 (m, 1 H), 1.88-1.83 (m, 7
= 6.4 Hz, 3 H), 1.80-1.35 (m, 7 = 6.4 Hz, 3 H), 0.64 (d, 7 = 6 .4 Hz, 1.2 H), 0.55 (d ,7 =
6.4 Hz, 1.8 H), 0.37 (d, 7 = 6.4 Hz, 1.2 H), 0.21 ( d ,7 = 6 .4 Hz, 1.8 H).

13C N M R (C D C 13,

100 M Hz): 5 137.7, 137.3, 130.6, 130.5, 130.4, 130.3, 129.6, 129.4,

61.5, 61.0, 58.6 (d,

J

p c

h

= 106.8 Hz), 58.0 (d,

J

p c

h

~ 103.8 Hz), 52.5 (d,

J

p o
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c

h

i

~ 6-1

Hz), 52.1 (d, Jpocm = 6.1 Hz), 39.3, 38.0, 32.8, 30.3, 25.9 (d, J = 9.2 H z), 25.7 (d, J
Hz), 2 3 .5 ,2 2 .9 ,2 2 .4 , 22.2.

31P N M R (CDC13, 171 MHz):

8

73.4, 72.9.
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ACE Assay

Phosphoram idon
lm L o f HEPES shall be added to the bottle o f Phosphoram idon.
50pL shall be transferred into each o f 20 E ppendorf tubes.
950pL o f le-4M HEPES shall be added to each tube w hen needed.
[Phosphoramidon] = 9.19963e-5M

FAGLA
277.8pL o f 95% EtOH shall be used to dissolve 25mg o f dipeptide.
40pL shall be transferred into each o f 5 E ppendorf tubes
960pL o f le-4M HEPES shall be added to each tube when needed.
[FAGLA] = 1.1747e-2M

Thermolysin
13.3067mL o f HEPES shall be used to dissolve 25m g o f protein in approximately
2mL aliquots at a time.
The aliquots were then transferred to a small centrifuge tube.
lm L o f suspension shall be transferred into each o f 13 E ppendorf tubes
lOOpL o f concentrate shall be diluted with 900pL o f le-4M HEPES when
needed.
[Thermolysin] = 5.01 e- 6 M

APTA compounds
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W eigh approxim ately l-2m g o f com pound and dissolve in 500pL o f EtOH
Calculate concentration and amount o f concentrate needed to produce lm L o f
9.19963e-5M compound.
[A PTA ’s] = 9.19963e-5M

500pL o f 2 .8 2 7 9 x l0 ‘3M FAGLA were diluted in 500pL o f 5 .0 1 x l0 '5 M enzyme
and 500pL o f pH 7.2, 1x1CT3M HEPES in a 96 well plate. The well plate was then
incubated at 30 EC for 5 min in the well plate reader. The decrease in the absorbance o f
FAGLA at L=345 was measured over a time o f 800 (later 180) seconds. A negative
control o f 500pL o f FAGLA solution diluted in 1000pL o f HEPES w as also performed to
make sure that the decreasing o f A 345 was due to the hydrolysis o f FA G LA instead o f its
natural decom position. A second control o f 500pJL o f therm olysin in 1000pL o f HEPES
was also perform ed to guarantee that the enzym e did not absorb at 345nm . Finally 500pL
o f FAGLA were m ixed with 500pL o f therm olysin and 500pL o f inhibitor, either the
known inhibitor phosphoram idon, or an APTA compound.
These three solutions were then also analyzed on the Beckm an U V -V isible
spectrophotometer. The data was collected by Softmax pro and analyzed in Excel.
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